ticker,rpa_date_utc,rpa_time_utc,rp_entity_id,entity_name,relevance,event_sentiment_score,group,sub_type,event_text,news_type,source_name,headline
IDXX,2024-01-17,15:28:24,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Buy by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Buy by Goldman Sachs
IDXX,2024-01-17,15:28:24,B7EB38,IDEXX Laboratories Inc.,100,0.8,price-targets,upgrade,Idexx Labs Price Target Raised to $650.00/Share From $500.00 by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $650.00/Share From $500.00 by Goldman Sachs
IDXX,2024-01-23,20:30:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results
IDXX,2024-01-23,20:30:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results
IDXX,2024-01-23,20:30:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results
IDXX,2024-01-23,20:40:42,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results
IDXX,2024-01-23,20:40:42,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results
IDXX,2024-01-23,20:40:42,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results
IDXX,2024-01-30,10:46:33,B7EB38,IDEXX Laboratories Inc.,100,-0.58,analyst-ratings,negative,Idexx Labs Cut to Neutral From Overweight by Piper Sandler,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Cut to Neutral From Overweight by Piper Sandler
IDXX,2024-01-30,10:46:33,B7EB38,IDEXX Laboratories Inc.,100,0.0,price-targets,set,Idexx Labs Price Target Announced at $525.00/Share by Piper Sandler,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Announced at $525.00/Share by Piper Sandler
IDXX,2024-02-05,11:30:00,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 4Q EPS $2.32,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 4Q EPS $2.32 >IDXX
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Announces Fourth Quarter and Full Year Results,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Announces Fourth Quarter and Full Year Results,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,"IDEXX Laboratories Inc.: The Company reports revenues of $902 million for the fourth quarter of 2023, an increase of 9% compared to the prior year",PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year -3-
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers fourth quarter EPS of $2.32,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Estimates 2024 EPS of $10.84 - $11.33,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Revenue for the full year,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,"IDEXX Laboratories Inc.: For the full year 2023, EPS of $10.06",PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company's 2024 revenue guidance,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,-0.24,revenues,down,IDEXX Laboratories Inc.: LPD revenue declined 2%,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 9%,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 27.2% in the quarter,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,-0.16,equity-actions,up,IDEXX Laboratories Inc.: Operating expenses grew 9%,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 4Q Net $194.5M,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 4Q Net $194.5M >IDXX
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact 0%,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year -2-
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will host a conference call today at 8:30 a.m. (Eastern)",PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year -2-
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs 4Q Rev $901.6M >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 4Q Rev $901.6M >IDXX
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,97,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year -3-
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.32 $ 2.05,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year -3-
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2024 comparable EPS growth,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year -3-
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year -3-
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year -4-
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2023",PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year -4-
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $901,601 $828,568",PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year -4-
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 526,167",PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year -4-
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year -4-
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $ 2.34 $ 2.08 $,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year -4-
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $ 2.32 $ 2.05 $,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year -4-
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,95,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $ 3,259,925 $ 2,746,765",PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year -6-
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,95,0.0,revenues,,IDEXX Laboratories Inc.: Selected Days sales,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year -6-
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,95,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year -6-
IDXX,2024-02-05,11:30:01,B7EB38,IDEXX Laboratories Inc.,93,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,Business Wire,IDEXX Announces Fourth Quarter and Full Year -7-
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Announces Fourth Quarter and Full Year Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Announces Fourth Quarter and Full Year Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,"IDEXX Laboratories Inc.: The Company reports revenues of $902 million for the fourth quarter of 2023, an increase of 9% compared to the prior year",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers fourth quarter EPS of $2.32,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Estimates 2024 EPS of $10.84 - $11.33,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Revenue for the full year,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,"IDEXX Laboratories Inc.: For the full year 2023, EPS of $10.06",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company's 2024 revenue guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,100,-0.24,revenues,down,IDEXX Laboratories Inc.: LPD revenue declined 2%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 27.2% in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,100,-0.16,equity-actions,up,IDEXX Laboratories Inc.: Operating expenses grew 9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and Full Year Results
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact 0%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and -2-
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will host a conference call today at 8:30 a.m. (Eastern)",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and -2-
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,97,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and -3-
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and -3-
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.32 $ 2.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and -3-
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,97,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2024 comparable EPS growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and -3-
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,97,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and -3-
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and -4-
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and -4-
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,99,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $901,601 $828,568",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and -4-
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 526,167",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and -4-
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and -4-
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $ 2.34 $ 2.08 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and -4-
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $ 2.32 $ 2.05 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and -4-
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,95,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $ 3,259,925 $ 2,746,765",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and -6-
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,95,0.0,revenues,,IDEXX Laboratories Inc.: Selected Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and -6-
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,95,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and -6-
IDXX,2024-02-05,11:30:20,B7EB38,IDEXX Laboratories Inc.,92,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces Fourth Quarter and -7-
IDXX,2024-02-05,11:31:31,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,"IDEXX Laboratories Inc.: the ""Company"") announced its financial results for the quarter and year ended December 31, 2023",RNS-SEC8K,Dow Jones Newswires,IDEXX Labs Files 8K - Operations And Financial Condition >IDXX
IDXX,2024-02-05,11:32:14,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs Sees 2024 Rev $3.93B-$4.04B >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2024 Rev $3.93B-$4.04B >IDXX
IDXX,2024-02-05,11:32:31,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Labs Sees 2024 EPS $10.84,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2024 EPS $10.84-EPS $11.33 >IDXX
IDXX,2024-02-05,11:48:07,B7EB38,IDEXX Laboratories Inc.,100,0.65,revenues,up,Idexx Posts Higher 4Q Revenue,FULL-ARTICLE,Dow Jones Newswires,"Idexx Posts Higher 4Q Revenue, Lifted by Veterinarian Demand"
IDXX,2024-02-06,15:54:52,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Barclays,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Barclays
IDXX,2024-02-06,15:54:52,B7EB38,IDEXX Laboratories Inc.,100,0.72,price-targets,upgrade,Idexx Labs Price Target Raised to $655.00/Share From $605.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $655.00/Share From $605.00 by Barclays
IDXX,2024-02-06,19:09:53,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by JP Morgan
IDXX,2024-02-06,19:09:53,B7EB38,IDEXX Laboratories Inc.,100,0.58,price-targets,upgrade,Idexx Labs Price Target Raised to $630.00/Share From $600.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $630.00/Share From $600.00 by JP Morgan
IDXX,2024-02-07,23:24:32,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Cfo McKeon Registers 23,326 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"CFO McKeon Registers 23,326 Of IDEXX Laboratories Inc >IDXX"
IDXX,2024-02-08,00:06:26,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Ceo Mazelsky Registers 12,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"CEO Mazelsky Registers 12,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2024-02-08,22:30:31,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Fennell Registers 8,198 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Fennell Registers 8,198 Of IDEXX Laboratories Inc >IDXX"
IDXX,2024-02-09,22:02:05,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Ceo Mazelsky Sells 12,000 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mazelsky Sells 12,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2024-02-09,22:03:16,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Cfo McKeon Sells 23,326 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CFO McKeon Sells 23,326 Of IDEXX Laboratories Inc >IDXX"
IDXX,2024-02-09,22:03:50,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,"Dir Ayers Gifts 1,850 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Gifts 1,850 Of IDEXX Laboratories Inc >IDXX"
IDXX,2024-02-09,22:04:56,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Fennell Sells 8,198 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Fennell Sells 8,198 Of IDEXX Laboratories Inc >IDXX"
IDXX,2024-02-12,22:08:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,"Dir Ayers Gifts 5,350 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Gifts 5,350 Of IDEXX Laboratories Inc >IDXX"
IDXX,2024-02-16,22:57:18,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Fennell Acquires 208 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Fennell Acquires 208 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-02-16,22:57:50,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Erickson Acquires 318 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Erickson Acquires 318 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-02-16,22:57:52,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Hunt Acquires 401 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Hunt Acquires 401 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-02-16,22:58:20,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Lane Acquires 656 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Lane Acquires 656 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-02-16,22:58:28,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Johnson Acquires 116 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Johnson Acquires 116 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-02-16,22:58:46,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Cfo McKeon Acquires 634 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,CFO McKeon Acquires 634 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-02-16,23:01:47,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Ceo Mazelsky Acquires 2,317 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mazelsky Acquires 2,317 Of IDEXX Laboratories Inc >IDXX"
IDXX,2024-02-16,23:11:04,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Polewaczyk Acquires 648 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Polewaczyk Acquires 648 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-02-16,23:11:14,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Schreck Acquires 251 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Schreck Acquires 251 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-02-16,23:11:33,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Smith Acquires 229 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Smith Acquires 229 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-02-16,23:39:55,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Underberg Acquires 830 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Underberg Acquires 830 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-02-19,08:01:23,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 4Q 2023 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories  Inc, Inst Holders, 4Q 2023 (IDXX)"
IDXX,2024-02-20,19:00:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Two Upcoming Institutional Investor Conferences,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
IDXX,2024-02-20,19:00:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Two Upcoming Institutional Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
IDXX,2024-02-20,22:09:58,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Cfo McKeon Acquires 483 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,CFO McKeon Acquires 483 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-02-20,22:11:43,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Underberg Acquires 483 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Underberg Acquires 483 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-02-22,22:03:40,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Ceo Mazelsky Acquires 483 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,CEO Mazelsky Acquires 483 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-03-04,23:52:05,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,Ceo Mazelsky Gifts 550 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,CEO Mazelsky Gifts 550 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-03-05,22:39:51,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Vandebroek Registers 1,404 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Vandebroek Registers 1,404 Of IDEXX Laboratories Inc >IDXX"
IDXX,2024-03-06,23:00:47,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Polewaczyk Registers 8,104 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Polewaczyk Registers 8,104 Of IDEXX Laboratories Inc >IDXX"
IDXX,2024-03-07,22:02:38,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Polewaczyk Sells 8,104 Of IDEXX Laboratories Inc",FULL-ARTICLE,Dow Jones Newswires,"VP Polewaczyk Sells 8,104 Of IDEXX Laboratories Inc >IDXX"
IDXX,2024-03-07,22:02:57,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Vandebroek Sells 1,404 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Vandebroek Sells 1,404 Of IDEXX Laboratories Inc >IDXX"
IDXX,2024-04-04,20:30:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2024 First Quarter Financial Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2024 First Quarter Financial Results
IDXX,2024-04-04,20:30:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2024 First Quarter Financial Results
IDXX,2024-04-04,20:35:51,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2024 First Quarter Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2024 First Quarter Financial Results
IDXX,2024-04-04,20:35:51,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2024 First Quarter Financial Results
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 1Q EPS $2.81,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 1Q EPS $2.81 >IDXX
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 1Q Net $235.6M,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 1Q Net $235.6M >IDXX
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs 1Q Rev $964.1M >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 1Q Rev $964.1M >IDXX
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces First Quarter Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Achieves first quarter revenue growth of 7%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Reported EPS included $0.10,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Updates 2024 revenue,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.64,earnings,up,IDEXX Laboratories Inc.: Updates 2024 EPS,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.51,products-services,increase,IDEXX Laboratories Inc.: High demand for IDEXX solutions,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: First quarter earnings per diluted share,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 5%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,-0.24,revenues,down,IDEXX Laboratories Inc.: LPD revenues declined 3%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 9%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 31.0% for the quarter,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Operating expense growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces First Quarter Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact ( 100 bps,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: The 2024 Annual Meeting,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.81 $ 2.55,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2024 comparable EPS growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,98,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,98,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,98,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $964,095 $900,195",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,98,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 593,070",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,98,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,98,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $ 2.84 $ 2.58,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,98,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $ 2.81 $ 2.55,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,95,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $3,353,515 $ 3,259,925",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -5-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,95,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -5-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,95,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -5-
IDXX,2024-05-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,91,0.59,equity-actions,,IDEXX Laboratories Inc.: repurchases,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -6-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: First Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Achieves first quarter revenue growth of 7%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Reported EPS included $0.10,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Updates 2024 revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,100,0.64,earnings,up,IDEXX Laboratories Inc.: Updates 2024 EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,100,0.51,products-services,increase,IDEXX Laboratories Inc.: High demand for IDEXX solutions,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: First quarter earnings per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,100,-0.24,revenues,down,IDEXX Laboratories Inc.: LPD revenues declined 3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 31.0% for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,100,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact ( 100 bps,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -2-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -2-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,IDEXX Laboratories Inc.: The 2024 Annual Meeting,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -2-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,99,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,99,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.81 $ 2.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2024 comparable EPS growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,98,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,98,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,98,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $964,095 $900,195",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,98,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 593,070",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,98,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,98,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $ 2.84 $ 2.58,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,98,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $ 2.81 $ 2.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,95,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $3,353,515 $ 3,259,925",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -5-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,95,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -5-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,95,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -5-
IDXX,2024-05-01,10:30:51,B7EB38,IDEXX Laboratories Inc.,90,0.59,equity-actions,,IDEXX Laboratories Inc.: repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -6-
IDXX,2024-05-01,10:31:36,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,"IDEXX Laboratories Inc.: the ""Company"") announced its financial results for the quarter ended March 31, 2024",RNS-SEC8K,Dow Jones Newswires,IDEXX Labs Files 8K - Operations And Financial Condition >IDXX
IDXX,2024-05-01,10:35:17,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs Sees 2024 Rev $3.895B-$3.965B >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2024 Rev $3.895B-$3.965B >IDXX
IDXX,2024-05-01,10:35:31,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Labs Sees 2024 EPS $10.82,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2024 EPS $10.82-EPS $11.20 >IDXX
IDXX,2024-05-01,10:36:32,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Labs Had Seen 2024 EPS $10.84-$11.33 >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Had Seen 2024 EPS $10.84-$11.33 >IDXX
IDXX,2024-05-01,10:36:58,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs Had Seen 2024 Revenue $3.93B-$4.04B,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Had Seen 2024 Revenue $3.93B-$4.04B >IDXX
IDXX,2024-05-01,10:55:36,B7EB38,IDEXX Laboratories Inc.,100,0.64,earnings,up,Idexx 1Q Net Up,FULL-ARTICLE,Dow Jones Newswires,Idexx 1Q Net Up; Lowers Guidance for The Year
IDXX,2024-05-01,10:55:36,B7EB38,IDEXX Laboratories Inc.,100,-0.74,earnings,down,Idexx cut its 2024 earnings projection,FULL-ARTICLE,Dow Jones Newswires,Idexx 1Q Net Up; Lowers Guidance for The Year
IDXX,2024-05-01,10:55:36,B7EB38,IDEXX Laboratories Inc.,100,-0.75,revenues,down,Idexx cut its projection for 2024 revenue,FULL-ARTICLE,Dow Jones Newswires,Idexx 1Q Net Up; Lowers Guidance for The Year
IDXX,2024-05-02,18:00:47,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Barclays,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Barclays
IDXX,2024-05-02,18:00:47,B7EB38,IDEXX Laboratories Inc.,100,-0.8,price-targets,downgrade,Idexx Labs Price Target Cut to $570.00/Share From $655.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $570.00/Share From $655.00 by Barclays
IDXX,2024-05-14,17:07:44,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Morgan Stanley
IDXX,2024-05-14,17:07:44,B7EB38,IDEXX Laboratories Inc.,100,-0.5,price-targets,downgrade,Idexx Labs Price Target Cut to $596.00/Share From $620.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $596.00/Share From $620.00 by Morgan Stanley
IDXX,2024-05-14,18:00:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Stifel Conference,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Present at Stifel Conference and Announces 2024 Investor Day
IDXX,2024-05-14,18:00:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Stifel Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Present at Stifel Conference and Announces 2024 Investor Day
IDXX,2024-05-17,19:51:25,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,Dir Claflin Registers 200 Of IDEXX Laboratories Inc >IDXX,RNS-SEC144,Dow Jones Newswires,Dir Claflin Registers 200 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-05-19,07:01:18,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 1Q 2024 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories  Inc, Inst Holders, 1Q 2024 (IDXX)"
IDXX,2024-05-20,21:03:37,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,Dir Claflin Sells 200 Of IDEXX Laboratories Inc,TABULAR-MATERIAL,Dow Jones Newswires,Dir Claflin Sells 200 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-06-24,13:05:34,B7EB38,IDEXX Laboratories Inc.,100,0.0,analyst-ratings,neutral,Idexx Labs Is Maintained at Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Hold by Stifel
IDXX,2024-06-24,13:05:34,B7EB38,IDEXX Laboratories Inc.,100,-0.36,price-targets,downgrade,Idexx Labs Price Target Cut to $510.00/Share From $520.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $510.00/Share From $520.00 by Stifel
IDXX,2024-06-24,15:00:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2024 Second Quarter Financial Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2024 Second Quarter Financial Results
IDXX,2024-06-24,15:00:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2024 Second Quarter Financial Results
IDXX,2024-06-24,15:02:40,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2024 Second Quarter Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2024 Second Quarter Financial Results
IDXX,2024-06-24,15:02:40,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2024 Second Quarter Financial Results
IDXX,2024-07-25,20:22:37,B7EB38,IDEXX Laboratories Inc.,100,0.95,analyst-ratings,positive,Idexx Labs Initiated at Buy by BTIG,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Initiated at Buy by BTIG
IDXX,2024-07-25,20:22:37,B7EB38,IDEXX Laboratories Inc.,100,0.0,price-targets,set,Idexx Labs Price Target Announced at $580.00/Share by BTIG,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Announced at $580.00/Share by BTIG
IDXX,2024-07-30,21:53:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Time Change for 2024 Second Quarter Financial Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Time Change for 2024 Second Quarter Financial Results Conference Call
IDXX,2024-07-30,21:53:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Time Change for 2024 Second Quarter Financial Results Conference Call
IDXX,2024-07-30,22:05:15,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Time Change for 2024 Second Quarter Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Time Change for 2024 Second Quarter Financial Results Conference Call
IDXX,2024-07-30,22:05:15,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Time Change for 2024 Second Quarter Financial Results Conference Call
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Second Quarter Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Achieves second quarter revenue growth of 6%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.44,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Updates 2024 revenue,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Adjusts 2024 EPS,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Second quarter earnings per diluted share,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 6%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 8%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 26.3% for the quarter,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: 2024 Growth and Financial Performance,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company updated its full year reported operating margin outlook,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact ( 50 bps,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -2-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 9:00 a.m. (EDT)",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -2-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,94,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,94,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.44 $ 2.67,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,94,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2024 comparable EPS growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2024",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $1,003,578 $943,630",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 619,159",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $2.46 $2.70,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $2.44 $2.67,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,2Q EPS $2.44 >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 2Q EPS $2.44 >IDXX
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -5-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 2Q Net $203.3M,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 2Q Net $203.3M >IDXX
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,96,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $3,414,867 $3,259,925",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -6-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,96,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -6-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,96,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -6-
IDXX,2024-08-06,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs 2Q Rev $1B >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 2Q Rev $1B >IDXX
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Second Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Achieves second quarter revenue growth of 6%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.44,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Updates 2024 revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Adjusts 2024 EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Second quarter earnings per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 6%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 8%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 26.3% for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: 2024 Growth and Financial Performance,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company updated its full year reported operating margin outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact ( 50 bps,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -2-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 9:00 a.m. (EDT)",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -2-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.44 $ 2.67,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2024 comparable EPS growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $1,003,578 $943,630",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 619,159",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $2.46 $2.70,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $2.44 $2.67,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -5-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,96,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $3,414,867 $3,259,925",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -6-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,96,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -6-
IDXX,2024-08-06,10:30:02,B7EB38,IDEXX Laboratories Inc.,90,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -7-
IDXX,2024-08-06,10:31:22,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,"IDEXX Laboratories Inc.: the ""Company"") announced its financial results for the quarter ended June 30, 2024",RNS-SEC8K,Dow Jones Newswires,IDEXX Labs Files 8K - Operations And Financial Condition >IDXX
IDXX,2024-08-06,10:36:59,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Labs Sees 2024 Adj EPS $10.31,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2024 Adj EPS $10.31-Adj EPS $10.59 >IDXX
IDXX,2024-08-06,10:37:21,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs Sees 2024 Rev $3.885B-$3.945B >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2024 Rev $3.885B-$3.945B >IDXX
IDXX,2024-08-07,21:05:38,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Ceo Mazelsky Acquires 214 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,CEO Mazelsky Acquires 214 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-08-07,21:07:21,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Cfo McKeon Acquires 75 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,CFO McKeon Acquires 75 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-08-14,16:09:22,B7EB38,IDEXX Laboratories Inc.,100,0.0,analyst-ratings,neutral,Idexx Labs Is Maintained at Neutral by Piper Sandler,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Neutral by Piper Sandler
IDXX,2024-08-14,16:09:22,B7EB38,IDEXX Laboratories Inc.,100,-0.8,price-targets,downgrade,Idexx Labs Price Target Cut to $520.00/Share From $600.00 by Piper Sandler,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $520.00/Share From $600.00 by Piper Sandler
IDXX,2024-08-19,07:01:11,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 2Q 2024 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories  Inc, Inst Holders, 2Q 2024 (IDXX)"
IDXX,2024-08-21,20:15:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Morgan Stanley 22(nd) Annual Global Healthcare Conference,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Present at Morgan Stanley 22(nd) Annual Global Healthcare Conference
IDXX,2024-08-21,20:15:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
IDXX,2024-09-05,00:08:56,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Smith Acquires 13 Of IDEXX Laboratories Inc >IDXX,FULL-ARTICLE,Dow Jones Newswires,VP Smith Acquires 13 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-09-05,00:25:50,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Schreck Acquires 116 Of IDEXX Laboratories Inc >IDXX,FULL-ARTICLE,Dow Jones Newswires,VP Schreck Acquires 116 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-09-06,20:39:46,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,Dir Szostak Registers 500 Of IDEXX Laboratories Inc >IDXX,RNS-SEC144,Dow Jones Newswires,Dir Szostak Registers 500 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-09-09,20:20:07,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,Dir Szostak Sells 500 Of IDEXX Laboratories Inc,FULL-ARTICLE,Dow Jones Newswires,Dir Szostak Sells 500 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-09-30,18:00:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2024 Third Quarter Financial Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2024 Third Quarter Financial Results
IDXX,2024-09-30,18:00:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2024 Third Quarter Financial Results
IDXX,2024-09-30,18:01:27,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2024 Third Quarter Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2024 Third Quarter Financial Results
IDXX,2024-09-30,18:01:27,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2024 Third Quarter Financial Results
IDXX,2024-10-10,15:28:19,B7EB38,IDEXX Laboratories Inc.,100,0.0,analyst-ratings,neutral,Idexx Labs Is Maintained at Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Hold by Stifel
IDXX,2024-10-10,15:28:19,B7EB38,IDEXX Laboratories Inc.,100,-0.38,price-targets,downgrade,Idexx Labs Price Target Cut to $500.00/Share From $510.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $500.00/Share From $510.00 by Stifel
IDXX,2024-10-11,14:20:31,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by JP Morgan
IDXX,2024-10-11,14:20:31,B7EB38,IDEXX Laboratories Inc.,100,-0.74,price-targets,downgrade,Idexx Labs Price Target Cut to $575.00/Share From $630.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $575.00/Share From $630.00 by JP Morgan
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,3Q EPS $2.80 >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 3Q EPS $2.80 >IDXX
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 3Q Net $232.8M,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 3Q Net $232.8M >IDXX
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs 3Q Rev $975.5M >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 3Q Rev $975.5M >IDXX
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Third Quarter Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Achieves third quarter revenue growth of 7%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.80,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Adjusts 2024 revenue,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Updates 2024 revenue growth guidance,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Narrows 2024 EPS,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company reports revenues of $976 million for the third quarter of 2024,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Third quarter earnings per diluted share,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 6%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,-0.24,revenues,down,IDEXX Laboratories Inc.: LPD revenues declined 3%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 9%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 31.2% for the quarter,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Operating expense growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: 2024 Growth and Financial Performance,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,-0.74,earnings,down,IDEXX Laboratories Inc.: The Company narrowed its EPS outlook,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Third Quarter Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results -2-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact ( 20 bps,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results -2-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results -2-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.80 $ 2.53,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2024 comparable EPS growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2024",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $975,543 $915,527",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 596,038",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $2.83 $2.55,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $2.80 $2.53,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,93,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -5-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,96,0.0,revenues,,IDEXX Laboratories Inc.: Net CAG September September Dollar Revenue,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -6-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,96,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $3,350,766 $3,259,925",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -6-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,96,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -6-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,91,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -7-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Third Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Achieves third quarter revenue growth of 7%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.80,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Adjusts 2024 revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Updates 2024 revenue growth guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Narrows 2024 EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company reports revenues of $976 million for the third quarter of 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Third quarter earnings per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 6%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,-0.24,revenues,down,IDEXX Laboratories Inc.: LPD revenues declined 3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 31.2% for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: 2024 Growth and Financial Performance,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,-0.74,earnings,down,IDEXX Laboratories Inc.: The Company narrowed its EPS outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact ( 20 bps,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -2-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -2-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.80 $ 2.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2024 comparable EPS growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $975,543 $915,527",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 596,038",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $2.83 $2.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $2.80 $2.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,93,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -5-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,96,0.0,revenues,,IDEXX Laboratories Inc.: Net CAG September September Dollar Revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -6-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,96,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $3,350,766 $3,259,925",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -6-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,96,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -6-
IDXX,2024-10-31,10:30:02,B7EB38,IDEXX Laboratories Inc.,91,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -7-
IDXX,2024-10-31,10:31:54,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,"IDEXX Laboratories Inc.: the ""Company"") announced its financial results for the quarter ended September 30, 2024",RNS-SEC8K,Dow Jones Newswires,IDEXX Labs Files 8K - Operations And Financial Condition >IDXX
IDXX,2024-10-31,10:33:52,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs Adjusts 2024 View To Rev $3.87B-$3.89B,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Adjusts 2024 View To Rev $3.87B-$3.89B >IDXX
IDXX,2024-10-31,10:34:03,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,Idexx Labs Updates 2024 Rev Growth Guidance to 5.5% - 6.2%,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Updates 2024 Rev Growth Guidance to 5.5% - 6.2% >IDXX
IDXX,2024-10-31,10:34:26,B7EB38,IDEXX Laboratories Inc.,100,-0.74,earnings,down,Idexx Labs Narrows 2024 View To EPS $10.37,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Narrows 2024 View To EPS $10.37-EPS $10.53 >IDXX
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Third Quarter Results,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Achieves third quarter revenue growth of 7%,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.80,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Adjusts 2024 revenue,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Updates 2024 revenue growth guidance,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Narrows 2024 EPS,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company reports revenues of $976 million for the third quarter of 2024,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Third quarter earnings per diluted share,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 6%,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,100,-0.24,revenues,down,IDEXX Laboratories Inc.: LPD revenues declined 3%,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 9%,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 31.2% for the quarter,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,100,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Operating expense growth,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: 2024 Growth and Financial Performance,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,99,-0.74,earnings,down,IDEXX Laboratories Inc.: The Company narrowed its EPS outlook,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -2-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Negative EPS,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -2-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: 2024 Growth and Financial Performance,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -2-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact ( 20 bps,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -2-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -2-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,99,0.65,revenues,up,IDEXX Laboratories Inc.: Constant currency revenue,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -3-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,99,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -3-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -3-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.80 $ 2.53,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -4-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2024 comparable EPS growth,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -4-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -4-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -4-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -4-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -4-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,99,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -3-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2024",PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -4-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $975,543 $915,527",PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -4-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 596,038",PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -4-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -4-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -5-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,96,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $3,350,766 $3,259,925",PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -6-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,96,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -6-
IDXX,2024-10-31,17:15:02,B7EB38,IDEXX Laboratories Inc.,92,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,Business Wire,CORRECTING and REPLACING IDEXX Laboratories -7-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Third Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Achieves third quarter revenue growth of 7%,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.80,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Adjusts 2024 revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Updates 2024 revenue growth guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Narrows 2024 EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company reports revenues of $976 million for the third quarter of 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Third quarter earnings per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 6%,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,100,-0.24,revenues,down,IDEXX Laboratories Inc.: LPD revenues declined 3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 31.2% for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,100,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: 2024 Growth and Financial Performance,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,99,-0.74,earnings,down,IDEXX Laboratories Inc.: The Company narrowed its EPS outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -2-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Negative EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -2-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: 2024 Growth and Financial Performance,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -2-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact ( 20 bps,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -2-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -2-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,99,0.65,revenues,up,IDEXX Laboratories Inc.: Constant currency revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -3-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -3-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.80 $ 2.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -4-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2024 comparable EPS growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -4-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -4-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -4-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -4-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -4-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -4-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,99,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $975,543 $915,527",PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -4-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 596,038",PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -4-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -4-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -5-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,96,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $3,350,766 $3,259,925",PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -6-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,96,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -6-
IDXX,2024-10-31,17:43:52,B7EB38,IDEXX Laboratories Inc.,92,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,Dow Jones Newswires,Press Release: CORRECTING and REPLACING IDEXX -7-
IDXX,2024-11-04,13:17:36,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Barclays,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Barclays
IDXX,2024-11-04,13:17:36,B7EB38,IDEXX Laboratories Inc.,100,-0.82,price-targets,downgrade,Idexx Labs Price Target Cut to $481.00/Share From $570.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $481.00/Share From $570.00 by Barclays
IDXX,2024-11-04,16:44:26,B7EB38,IDEXX Laboratories Inc.,100,-0.82,price-targets,downgrade,Idexx Labs Price Target Cut to $435.00/Share From $520.00 by Piper Sandler,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $435.00/Share From $520.00 by Piper Sandler
IDXX,2024-11-06,21:01:17,B7EB38,IDEXX Laboratories Inc.,96,0.0,earnings,,"Idexx's Annual Report on Form 10-K for the year ended December 31, 2023",RNS-SEC8K,Dow Jones Newswires,IDEXX Labs Files 8K - Entry Into Definitive Agreement >IDXX
IDXX,2024-11-12,14:00:07,B7EB38,IDEXX Laboratories Inc.,99,0.49,partnerships,,"New endorsement partnership with IDEXX Laboratories, Inc.",PRESS-RELEASE,Business Wire,ACVIM and IDEXX Partner to Provide Free Educational Offerings for ACVIM Residents
IDXX,2024-11-12,14:25:38,B7EB38,IDEXX Laboratories Inc.,99,-0.51,labor-issues,,"IDEXX Laboratories Inc.: the ""Company""), resigned from the Board",RNS-SEC8K,Dow Jones Newswires,"IDEXX Labs Files 8K - Director, Officer or Compensation Filing >IDXX"
IDXX,2024-11-12,15:00:31,B7EB38,IDEXX Laboratories Inc.,100,-0.51,labor-issues,,Idexx Laboratories: Jonnathan W. Ayers Resigned From Board,RNS-SEC8K,Dow Jones Newswires,IDEXX Laboratories: Jonnathan W. Ayers Resigned From Board
IDXX,2024-11-19,08:01:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 3Q 2024 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories  Inc, Inst Holders, 3Q 2024 (IDXX)"
IDXX,2024-11-21,12:30:00,B7EB38,IDEXX Laboratories Inc.,100,0.53,labor-issues,,Idexx Announces CFO Transition,PRESS-RELEASE,Business Wire,IDEXX Announces CFO Transition
IDXX,2024-11-21,12:30:00,B7EB38,IDEXX Laboratories Inc.,100,0.53,labor-issues,,Will succeed Mr. McKeon as IDEXX's Executive Vice President,PRESS-RELEASE,Business Wire,IDEXX Announces CFO Transition
IDXX,2024-11-21,12:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.53,labor-issues,,Idexx Announces CFO Transition,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces CFO Transition
IDXX,2024-11-21,12:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.53,labor-issues,,Will succeed Mr. McKeon as IDEXX's Executive Vice President,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Announces CFO Transition
IDXX,2024-11-21,12:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.53,labor-issues,,Idexx Announces CFO Transition,NEWS-FLASH,Dow Jones Newswires,IDEXX Announces CFO Transition
IDXX,2024-11-21,12:30:46,B7EB38,IDEXX Laboratories Inc.,100,-0.49,labor-issues,,Idexx Labs Chief Financial Officer Brian McKeon to Retire,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Chief Financial Officer Brian McKeon to Retire >IDXX
IDXX,2024-11-21,12:47:15,B7EB38,IDEXX Laboratories Inc.,100,-0.49,labor-issues,,Idexx Laboratories Finance Chief Brian McKeon to Retire,FULL-ARTICLE,Dow Jones Newswires,IDEXX Laboratories Finance Chief Brian McKeon to Retire
IDXX,2024-11-21,12:47:15,B7EB38,IDEXX Laboratories Inc.,100,-0.49,labor-issues,,"Idexx Laboratories' top finance executive, Brian McKeon, is retiring",FULL-ARTICLE,Dow Jones Newswires,IDEXX Laboratories Finance Chief Brian McKeon to Retire
IDXX,2024-11-27,21:39:36,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,Dir Vandebroek Registers 344 Of IDEXX Laboratories Inc >IDXX,RNS-SEC144,Dow Jones Newswires,Dir Vandebroek Registers 344 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-11-29,22:01:19,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,Dir Vandebroek Sells 344 Of IDEXX Laboratories Inc,FULL-ARTICLE,Dow Jones Newswires,Dir Vandebroek Sells 344 Of IDEXX Laboratories Inc >IDXX
IDXX,2024-12-02,13:12:53,B7EB38,IDEXX Laboratories Inc.,100,0.95,analyst-ratings,positive,Idexx Labs Initiated at Outperform by Leerink,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Initiated at Outperform by Leerink Partners
IDXX,2024-12-02,13:12:53,B7EB38,IDEXX Laboratories Inc.,100,0.0,price-targets,set,Idexx Labs Price Target Announced at $500.00/Share by Leerink,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Announced at $500.00/Share by Leerink Partners
IDXX,2024-12-09,12:30:00,B7EB38,IDEXX Laboratories Inc.,100,0.59,equity-actions,extended,Idexx Laboratories Announces Increase In Share Repurchase Program,NEWS-FLASH,Dow Jones Newswires,IDEXX Laboratories Announces Increase In Share Repurchase Program Authorization >IDXX
IDXX,2024-12-09,12:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.59,equity-actions,extended,Idexx Laboratories Announces Increase in Share Repurchase Program,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization
IDXX,2024-12-09,12:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.59,equity-actions,extended,Idexx Laboratories Announces Increase in Share Repurchase Program,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization
IDXX,2024-12-12,21:01:15,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Annual Report on Form 10-K for the fiscal year ending December 31, 2024",RNS-SEC8K,Dow Jones Newswires,"IDEXX Labs Files 8K - Director, Officer or Compensation Filing >IDXX"
IDXX,2021-01-08,13:29:27,B7EB38,IDEXX Laboratories Inc.,100,0.78,price-targets,upgrade,Idexx Laboratories price target raised to $520 from $470 at Stifel,NEWS-FLASH,MarketWatch,"MW Idexx Laboratories price target raised to $520 from $470 at Stifel, stock rated buy"
IDXX,2021-01-11,19:00:04,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2020 Fourth Quarter and Full-Year Financial Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2020 Fourth Quarter and Full-Year Financial Results
IDXX,2021-01-11,19:00:04,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2020 Fourth Quarter and Full-Year Financial Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2020 Fourth Quarter and Full-Year Financial Results
IDXX,2021-01-11,19:00:04,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2020 Fourth Quarter and Full-Year Financial Results
IDXX,2021-01-11,19:00:04,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2020 Fourth Quarter and Full-Year Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2020 Fourth Quarter and Full-Year Financial Results
IDXX,2021-01-11,19:00:04,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2020 Fourth Quarter and Full-Year Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2020 Fourth Quarter and Full-Year Financial Results
IDXX,2021-01-11,19:00:04,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2020 Fourth Quarter and Full-Year Financial Results
IDXX,2021-01-23,08:25:52,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 4Q 2020 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories Inc, Inst Holders, 4Q 2020 (IDXX)"
IDXX,2021-01-29,12:16:00,B7EB38,IDEXX Laboratories Inc.,100,0.95,analyst-ratings,positive,Idexx Laboratories started at overweight,NEWS-FLASH,MarketWatch,MW IDEXX Laboratories started at overweight with $570 stock price target at J.P. Morgan
IDXX,2021-01-29,12:52:09,B7EB38,IDEXX Laboratories Inc.,100,0.95,analyst-ratings,positive,Idexx Labs Initiated at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Initiated at Overweight by JP Morgan
IDXX,2021-01-29,12:52:09,B7EB38,IDEXX Laboratories Inc.,100,0.0,price-targets,set,Idexx Labs Price Target Announced at $570.00/Share by JP Morgan,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Announced at $570.00/Share by JP Morgan
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 4Q EPS $2.01,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 4Q EPS $2.01 >IDXX
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Fourth Quarter and Full Year 2020 Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Fourth Quarter and Full Year 2020 Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: The Company reports revenues of $721 million for the fourth quarter of 2020,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,"IDEXX Laboratories Inc.: For the full year 2020, EPS of $6.71",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Strong full year EPS,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Estimates 2021 EPS of $7.39 - $7.71,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Revenue for the full year,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.48,revenues,up,IDEXX Laboratories Inc.: The Company expects full year 2021 revenue growth of 13% - 15.5%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.65,revenues,up,IDEXX Laboratories Inc.: Revenue growth at U.S.,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,-0.68,revenues,down,Decline in IDEXX VetLab instrument revenues,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.42,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 24%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 25.7% in the quarter,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,-0.13,equity-actions,up,IDEXX Laboratories Inc.: Operating expenses increased 4%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 4Q Net $174.8M,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 4Q Net $174.8M >IDXX
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact 1.5% -2.0%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -2-
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will host a conference call today at 8:30 a.m.",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -2-
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs 4Q Rev $720.9M >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 4Q Rev $720.9M >IDXX
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,99,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -3-
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,99,0.62,earnings,up,"IDEXX Laboratories Inc.: operating profit growth, and operating margin gain for the Company",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -3-
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -3-
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -3-
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,99,0.53,labor-issues,,IDEXX Laboratories Inc.: CEO transition,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -3-
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,99,-0.57,labor-issues,,"IDEXX Laboratories Inc.: our former Chairman of the Board, President and Chief Executive Officer, stepped down",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -3-
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,96,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -5-
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Fourth Quarter and Full Year 2020 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Fourth Quarter and Full Year 2020 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: The Company reports revenues of $721 million for the fourth quarter of 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,"IDEXX Laboratories Inc.: For the full year 2020, EPS of $6.71",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Strong full year EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Estimates 2021 EPS of $7.39 - $7.71,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Revenue for the full year,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.48,revenues,up,IDEXX Laboratories Inc.: The Company expects full year 2021 revenue growth of 13% - 15.5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.65,revenues,up,IDEXX Laboratories Inc.: Revenue growth at U.S.,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,-0.68,revenues,down,Decline in IDEXX VetLab instrument revenues,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.42,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 24%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 25.7% in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,100,-0.13,equity-actions,up,IDEXX Laboratories Inc.: Operating expenses increased 4%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact 1.5% -2.0%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -2-
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will host a conference call today at 8:30 a.m.",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -2-
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,99,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,99,0.62,earnings,up,"IDEXX Laboratories Inc.: operating profit growth, and operating margin gain for the Company",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,99,0.53,labor-issues,,IDEXX Laboratories Inc.: CEO transition,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,99,-0.57,labor-issues,,"IDEXX Laboratories Inc.: our former Chairman of the Board, President and Chief Executive Officer, stepped down",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2021-02-02,11:30:06,B7EB38,IDEXX Laboratories Inc.,96,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -5-
IDXX,2021-02-02,11:30:59,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Labs Sees 2021 EPS $7.39,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2021 EPS $7.39-EPS $7.71 >IDXX
IDXX,2021-02-02,11:54:35,B7EB38,IDEXX Laboratories Inc.,100,0.86,earnings,above-expectations,"Idexx Earnings Jump, Beat Views",FULL-ARTICLE,Dow Jones Newswires,"Idexx Earnings Jump, Beat Views in 4Q"
IDXX,2021-02-02,11:54:35,B7EB38,IDEXX Laboratories Inc.,100,0.64,earnings,up,Idexx Laboratories Inc.'s profit nearly doubled,FULL-ARTICLE,Dow Jones Newswires,"Idexx Earnings Jump, Beat Views in 4Q"
IDXX,2021-02-02,11:54:35,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx said it estimates earnings per share of $7.39 to $7.71,FULL-ARTICLE,Dow Jones Newswires,"Idexx Earnings Jump, Beat Views in 4Q"
IDXX,2021-02-02,16:52:48,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories, Inc. CEO Jay Mazelsky on Q4 2020 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"IDEXX Laboratories, Inc. CEO Jay Mazelsky on Q4 2020 Results -- Earnings Call Transcript >IDXX"
IDXX,2021-02-02,16:52:48,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx-laboratories-inc-idxx-ceo-jay-mazelsky-on-q4-2020-results-earnings,NEWS-FLASH,Dow Jones Newswires,"IDEXX Laboratories, Inc. CEO Jay Mazelsky on Q4 2020 Results -- Earnings Call Transcript >IDXX"
IDXX,2021-02-08,23:06:35,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Szostak Sells 11,876 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Szostak Sells 11,876 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-02-16,21:30:05,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Two Upcoming Institutional Investor Conferences,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
IDXX,2021-02-16,21:30:05,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Two Upcoming Institutional Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
IDXX,2021-02-16,21:33:02,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Vandebroek Registers 3,046 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Vandebroek Registers 3,046 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-02-16,22:08:44,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Vandebroek Sells 3,046 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Vandebroek Sells 3,046 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-02-17,12:00:22,B7EB38,IDEXX Laboratories Inc.,100,0.95,analyst-ratings,positive,Idexx Labs Initiated at Overweight by Barclays,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Initiated at Overweight by Barclays
IDXX,2021-02-17,12:00:22,B7EB38,IDEXX Laboratories Inc.,100,0.0,price-targets,set,Idexx Labs Price Target Announced at $600.00/Share by Barclays,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Announced at $600.00/Share by Barclays
IDXX,2021-02-17,22:41:41,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,Vp Lane Registers 850 Of IDEXX Laboratories Inc >IDXX,RNS-SEC144,Dow Jones Newswires,VP Lane Registers 850 Of IDEXX Laboratories Inc >IDXX
IDXX,2021-02-17,22:41:51,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Cfo McKeon Registers 1,307 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"CFO McKeon Registers 1,307 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-02-18,00:32:09,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Hunt Acquires 498 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Hunt Acquires 498 Of IDEXX Laboratories Inc >IDXX
IDXX,2021-02-18,00:32:20,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,Vp Lane Sells 850 Of IDEXX Laboratories Inc,TABULAR-MATERIAL,Dow Jones Newswires,VP Lane Sells 850 Of IDEXX Laboratories Inc >IDXX
IDXX,2021-02-18,00:32:52,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Ceo Mazelsky Acquires 1,663 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mazelsky Acquires 1,663 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-02-18,00:34:41,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Cfo McKeon Sells 1,307 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CFO McKeon Sells 1,307 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-02-18,00:35:45,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Turner Acquires 599 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Turner Acquires 599 Of IDEXX Laboratories Inc >IDXX
IDXX,2021-02-18,00:35:54,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Polewaczyk Acquires 732 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Polewaczyk Acquires 732 Of IDEXX Laboratories Inc >IDXX
IDXX,2021-02-18,00:36:05,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Twigge Acquires 788 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Twigge Acquires 788 Of IDEXX Laboratories Inc >IDXX
IDXX,2021-02-18,00:36:40,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Underberg Acquires 492 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Underberg Acquires 492 Of IDEXX Laboratories Inc >IDXX
IDXX,2021-02-18,23:30:02,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Ceo Mazelsky Registers 13,868 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"CEO Mazelsky Registers 13,868 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-02-19,00:28:24,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Claflin Sells 7,331 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Claflin Sells 7,331 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-02-19,21:05:38,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Ayers Registers 1,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Ayers Registers 1,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-02-19,22:03:05,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Ceo Mazelsky Sells 13,868 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mazelsky Sells 13,868 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-02-19,22:03:25,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Cfo McKeon Acquires 1,474 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"CFO McKeon Acquires 1,474 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-02-22,23:01:02,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Ayers Sells 1,000 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Sells 1,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-02-24,16:05:30,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Junius Registers 1,898 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Junius Registers 1,898 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-02-24,22:03:54,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Junius Sells 1,898 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Junius Sells 1,898 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-02-24,22:04:56,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Ceo Mazelsky Acquires 1,475 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mazelsky Acquires 1,475 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-02-24,22:06:31,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Underberg Acquires 483 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Underberg Acquires 483 Of IDEXX Laboratories Inc >IDXX
IDXX,2021-02-26,00:36:03,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Dir Ayers Acquires 1,476 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Acquires 1,476 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-02-26,00:37:00,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Henderson Sells 3,046 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Henderson Sells 3,046 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-03-01,22:13:20,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Vp Polewaczyk Acquires 1,476 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"VP Polewaczyk Acquires 1,476 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-03-01,22:15:55,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Vp Twigge Acquires 3,227 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"VP Twigge Acquires 3,227 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-04-08,17:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2021 First Quarter Financial Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2021 First Quarter Financial Results
IDXX,2021-04-08,17:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2021 First Quarter Financial Results
IDXX,2021-04-08,17:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2021 First Quarter Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2021 First Quarter Financial Results
IDXX,2021-04-08,17:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2021 First Quarter Financial Results
IDXX,2021-04-23,07:51:55,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 1Q 2021 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories Inc, Inst Holders, 1Q 2021 (IDXX)"
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces First Quarter Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.42,revenues,up,IDEXX Laboratories Inc.: Achieves reported revenue growth of 24,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.35,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.72,revenues,up,"IDEXX Laboratories Inc.: Increases 2021 revenue guidance to $3,105 million - $3,160 million",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.7,earnings,up,IDEXX Laboratories Inc.: Raises 2021 EPS outlook to $7.88 - $8.18,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company reports revenues of $778 million for the first quarter of 2021,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.62,revenues,up,IDEXX Laboratories Inc.: Average same-store revenue growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.26,revenues,,IDEXX Laboratories Inc.: Rapid assay products revenues grew 21%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.48,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 31%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 31.8% in the quarter,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,-0.13,equity-actions,up,IDEXX Laboratories Inc.: Operating expenses increased 4%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 1Q EPS $2.35,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 1Q EPS $2.35 >IDXX
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 1Q Net $204.3M,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 1Q Net $204.3M >IDXX
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces First Quarter Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,equity-actions,,IDEXX Laboratories Inc.: Capital Expenditures $120 - $140,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact 1.5%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: 2021 Annual Meeting,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs 1Q Rev $777.7M >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 1Q Rev $777.7M >IDXX
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.65,revenues,up,IDEXX Laboratories Inc.: Constant currency revenue growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,99,-0.49,equity-actions,up,"IDEXX Laboratories Inc.: Operating expenses (as reported) $223,160 $215,265",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.62,earnings,up,IDEXX Laboratories Inc.: operating profit growth and comparable operating margin gain for the Company,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Comparable EPS,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2021 comparable EPS growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.0,assets,,"IDEXX Laboratories Inc.: March 31, December 31, 2021 2020 Assets",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,96,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -5-
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,96,0.0,equity-actions,,"IDEXX Laboratories Inc.: Cost of shares repurchased in the open market $139,213 $179,623",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -5-
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces First Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.42,revenues,up,IDEXX Laboratories Inc.: Achieves reported revenue growth of 24,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.35,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.72,revenues,up,"IDEXX Laboratories Inc.: Increases 2021 revenue guidance to $3,105 million - $3,160 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.7,earnings,up,IDEXX Laboratories Inc.: Raises 2021 EPS outlook to $7.88 - $8.18,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company reports revenues of $778 million for the first quarter of 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.62,revenues,up,IDEXX Laboratories Inc.: Average same-store revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.26,revenues,,IDEXX Laboratories Inc.: Rapid assay products revenues grew 21%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.48,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 31%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 31.8% in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,100,-0.13,equity-actions,up,IDEXX Laboratories Inc.: Operating expenses increased 4%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact 1.5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -2-
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -2-
IDXX,2021-05-04,10:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,IDEXX Laboratories Inc.: 2021 Annual Meeting,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -2-
IDXX,2021-05-04,10:30:09,B7EB38,IDEXX Laboratories Inc.,99,0.65,revenues,up,IDEXX Laboratories Inc.: Constant currency revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2021-05-04,10:30:09,B7EB38,IDEXX Laboratories Inc.,99,-0.49,equity-actions,up,"IDEXX Laboratories Inc.: Operating expenses (as reported) $223,160 $215,265",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2021-05-04,10:30:09,B7EB38,IDEXX Laboratories Inc.,99,0.62,earnings,up,IDEXX Laboratories Inc.: operating profit growth and comparable operating margin gain for the Company,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2021-05-04,10:30:09,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Comparable EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2021-05-04,10:30:09,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2021 comparable EPS growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2021-05-04,10:30:09,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2021-05-04,10:30:09,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2021-05-04,10:30:09,B7EB38,IDEXX Laboratories Inc.,99,0.0,assets,,"IDEXX Laboratories Inc.: March 31, December 31, 2021 2020 Assets",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2021-05-04,10:30:09,B7EB38,IDEXX Laboratories Inc.,96,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -5-
IDXX,2021-05-04,10:30:09,B7EB38,IDEXX Laboratories Inc.,96,0.0,equity-actions,,"IDEXX Laboratories Inc.: Cost of shares repurchased in the open market $139,213 $179,623",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -5-
IDXX,2021-05-04,10:35:47,B7EB38,IDEXX Laboratories Inc.,100,0.72,revenues,up,Idexx Labs Raises 2021 View To Rev $3.105B-$3.16B,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Raises 2021 View To Rev $3.105B-$3.16B >IDXX
IDXX,2021-05-04,10:36:24,B7EB38,IDEXX Laboratories Inc.,100,0.7,earnings,up,Idexx Labs Raises 2021 View To EPS $7.88,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Raises 2021 View To EPS $7.88-EPS $8.18 >IDXX
IDXX,2021-05-04,11:32:52,B7EB38,IDEXX Laboratories Inc.,100,0.7,earnings,up,Idexx Labs Raises Guidance as,FULL-ARTICLE,Dow Jones Newswires,IDEXX Labs Raises Guidance as 1Q Results Top Estimates >IDXX
IDXX,2021-05-04,11:32:52,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx reported adjusted earnings of $2.09 a share for the quarter,FULL-ARTICLE,Dow Jones Newswires,IDEXX Labs Raises Guidance as 1Q Results Top Estimates >IDXX
IDXX,2021-05-04,18:16:54,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories, Inc. CEO Jay Mazelsky on Q1 2021 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"IDEXX Laboratories, Inc. CEO Jay Mazelsky on Q1 2021 Results -- Earnings Call Transcript >IDXX"
IDXX,2021-05-04,18:16:54,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx-laboratories-inc-idxx-ceo-jay-mazelsky-on-q1-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,"IDEXX Laboratories, Inc. CEO Jay Mazelsky on Q1 2021 Results -- Earnings Call Transcript >IDXX"
IDXX,2021-05-11,18:53:35,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Ayers Registers 8,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Ayers Registers 8,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-05-12,23:48:12,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,Dir Ayers Sells 512 Of IDEXX Laboratories Inc,TABULAR-MATERIAL,Dow Jones Newswires,Dir Ayers Sells 512 Of IDEXX Laboratories Inc >IDXX
IDXX,2021-05-19,21:32:39,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Ayers Registers 7,632 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Ayers Registers 7,632 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-05-19,22:08:50,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Turner Kathy V & Scott H Registers 5,900 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Turner Kathy V & Scott H Registers 5,900 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-05-20,21:34:38,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Ayers Sells 7,632 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Sells 7,632 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-05-20,21:35:34,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,Ceo Mazelsky Gifts 500 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,CEO Mazelsky Gifts 500 Of IDEXX Laboratories Inc >IDXX
IDXX,2021-05-21,17:44:31,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Ayers Registers 5,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Ayers Registers 5,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-05-24,18:50:32,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Junius Registers 2,500 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Junius Registers 2,500 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-05-24,22:15:53,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Ayers Sells 5,000 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Sells 5,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-05-24,22:16:09,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Turner Sells 3,000 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Turner Sells 3,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-05-24,22:17:00,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Junius Sells 2,500 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Junius Sells 2,500 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-05-25,19:26:43,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Ayers Registers 5,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Ayers Registers 5,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-05-26,15:45:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Stifel Conference,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Present at Stifel Conference and Announces 2021 Virtual Investor Day
IDXX,2021-05-26,15:45:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Stifel Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Present at Stifel Conference and Announces 2021 Virtual Investor Day
IDXX,2021-05-26,19:29:41,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Ayers Registers 5,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Ayers Registers 5,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-05-26,21:31:45,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Ayers Sells 10,000 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Sells 10,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-05-26,21:31:57,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Turner Sells 2,900 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Turner Sells 2,900 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-05-28,18:05:50,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Polewaczyk Registers 8,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Polewaczyk Registers 8,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-06-01,20:05:32,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Turner Kathy V & Scott H Registers 3,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Turner Kathy V & Scott H Registers 3,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-06-01,20:23:36,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Ayers Registers 10,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Ayers Registers 10,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-06-01,20:26:30,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Polewaczyk Registers 10,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Polewaczyk Registers 10,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-06-01,22:01:40,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Ayers Sells 9,460 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Sells 9,460 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-06-01,22:02:26,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Polewaczyk Sells 10,000 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Polewaczyk Sells 10,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-06-01,22:03:02,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Turner Sells 2,000 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Turner Sells 2,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-06-02,20:26:06,B7EB38,IDEXX Laboratories Inc.,100,0.62,acquisitions-mergers,,Idexx Acquires EzyVet >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Acquires EzyVet >IDXX
IDXX,2021-06-02,20:27:11,B7EB38,IDEXX Laboratories Inc.,100,0.62,acquisitions-mergers,,Idexx Labs Acquires EzyVet for Undisclosed Terms,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Acquires EzyVet for Undisclosed Terms >IDXX
IDXX,2021-06-30,20:05:04,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2021 Second Quarter Financial Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2021 Second Quarter Financial Results
IDXX,2021-06-30,20:05:04,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2021 Second Quarter Financial Results
IDXX,2021-06-30,20:05:04,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2021 Second Quarter Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2021 Second Quarter Financial Results
IDXX,2021-06-30,20:05:04,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2021 Second Quarter Financial Results
IDXX,2021-07-12,11:41:54,B7EB38,IDEXX Laboratories Inc.,100,-0.58,analyst-ratings,negative,Idexx Labs Cut to Neutral From Buy by Guggenheim,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Cut to Neutral From Buy by Guggenheim
IDXX,2021-07-23,07:54:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 2Q 2021 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories Inc, Inst Holders, 2Q 2021 (IDXX)"
IDXX,2021-07-27,14:13:31,B7EB38,IDEXX Laboratories Inc.,100,0.8,price-targets,upgrade,Idexx Laboratories stock price target raised to $750 from $585 at BofA Securities,NEWS-FLASH,MarketWatch,MW IDEXX Laboratories stock price target raised to $750 from $585 at BofA Securities
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 2Q EPS $2.34,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 2Q EPS $2.34 >IDXX
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 2Q Net $202.6M,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 2Q Net $202.6M >IDXX
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs 2Q Rev $826.1M >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 2Q Rev $826.1M >IDXX
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Second Quarter Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,100,0.66,revenues,up,IDEXX Laboratories Inc.: Water revenues grew 32% on a reported basis,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.34,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,100,0.72,revenues,up,"IDEXX Laboratories Inc.: Increases 2021 revenue guidance to $3,170 million - $3,205 million",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,100,0.7,earnings,up,IDEXX Laboratories Inc.: Raises 2021 EPS outlook to $8.20 - $8.36,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company reports revenues of $826 million for the second quarter of 2021,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,100,0.62,revenues,up,IDEXX Laboratories Inc.: Average same-store revenue growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,100,0.46,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 30%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,100,0.46,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 29%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 31.4% in the quarter,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,100,-0.36,equity-actions,up,IDEXX Laboratories Inc.: Operating expenses increased 24%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact 2%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -2-
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -2-
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,96,0.41,revenues,up,IDEXX Laboratories Inc.: Diagnostics recurring revenue growth by 20 basis points,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,96,-0.49,equity-actions,up,"IDEXX Laboratories Inc.: Operating expenses (as reported) $230,055 $186,094",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,96,0.62,earnings,up,IDEXX Laboratories Inc.: operating profit growth and comparable operating margin gain for the Company,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,96,0.0,earnings,,IDEXX Laboratories Inc.: Comparable EPS,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,96,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2021 comparable EPS growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,96,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,97,0.0,assets,,"IDEXX Laboratories Inc.: June 30, 2021 December 31, 2020 Assets",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -5-
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,97,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -5-
IDXX,2021-07-30,10:30:17,B7EB38,IDEXX Laboratories Inc.,92,0.0,equity-actions,,"IDEXX Laboratories Inc.: Cost of shares repurchased in the open market $188,409 $",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -6-
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Second Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,100,0.66,revenues,up,IDEXX Laboratories Inc.: Water revenues grew 32% on a reported basis,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.34,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,100,0.72,revenues,up,"IDEXX Laboratories Inc.: Increases 2021 revenue guidance to $3,170 million - $3,205 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,100,0.7,earnings,up,IDEXX Laboratories Inc.: Raises 2021 EPS outlook to $8.20 - $8.36,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company reports revenues of $826 million for the second quarter of 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,100,0.62,revenues,up,IDEXX Laboratories Inc.: Average same-store revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,100,0.46,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 30%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,100,0.46,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 29%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 31.4% in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,100,-0.36,equity-actions,up,IDEXX Laboratories Inc.: Operating expenses increased 24%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact 2%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -2-
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -2-
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,96,0.41,revenues,up,IDEXX Laboratories Inc.: Diagnostics recurring revenue growth by 20 basis points,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,96,-0.49,equity-actions,up,"IDEXX Laboratories Inc.: Operating expenses (as reported) $230,055 $186,094",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,96,0.62,earnings,up,IDEXX Laboratories Inc.: operating profit growth and comparable operating margin gain for the Company,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,96,0.0,earnings,,IDEXX Laboratories Inc.: Comparable EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,96,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2021 comparable EPS growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,96,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,97,0.0,assets,,"IDEXX Laboratories Inc.: June 30, 2021 December 31, 2020 Assets",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -5-
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,97,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -5-
IDXX,2021-07-30,10:30:18,B7EB38,IDEXX Laboratories Inc.,92,0.0,equity-actions,,"IDEXX Laboratories Inc.: Cost of shares repurchased in the open market $188,409 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -6-
IDXX,2021-07-30,10:35:24,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs Sees FY Rev $3.17B-$3.205B >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees FY Rev $3.17B-$3.205B >IDXX
IDXX,2021-07-30,10:35:42,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Labs Sees FY EPS $8.20,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees FY EPS $8.20-EPS $8.36 >IDXX
IDXX,2021-07-30,10:52:29,B7EB38,IDEXX Laboratories Inc.,100,0.48,revenues,up,Idexx's guidance would represent revenue growth of 17% to 18.5% year,FULL-ARTICLE,Dow Jones Newswires,"Idexx Labs Raises Sales, Earnings Guidance for 2021"
IDXX,2021-07-30,10:52:29,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,"In May, Idexx was forecasting revenue of $3.11 billion to $3.16 billion",FULL-ARTICLE,Dow Jones Newswires,"Idexx Labs Raises Sales, Earnings Guidance for 2021"
IDXX,2021-07-30,19:29:12,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories, Inc. CEO Jay Mazelsky on Q2 2021 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"IDEXX Laboratories, Inc. CEO Jay Mazelsky on Q2 2021 Results -- Earnings Call Transcript >IDXX"
IDXX,2021-07-30,19:29:12,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx-laboratories-inc-idxx-ceo-jay-mazelsky-on-q2-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,"IDEXX Laboratories, Inc. CEO Jay Mazelsky on Q2 2021 Results -- Earnings Call Transcript >IDXX"
IDXX,2021-08-02,13:09:34,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Barclays,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Barclays
IDXX,2021-08-02,13:09:34,B7EB38,IDEXX Laboratories Inc.,100,0.78,price-targets,upgrade,Idexx Labs Price Target Raised to $750.00/Share From $616.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $750.00/Share From $616.00 by Barclays
IDXX,2021-08-03,14:44:41,B7EB38,IDEXX Laboratories Inc.,100,0.0,analyst-ratings,neutral,Idexx Labs Is Maintained at Neutral by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Neutral by Goldman Sachs
IDXX,2021-08-03,14:44:41,B7EB38,IDEXX Laboratories Inc.,100,0.78,price-targets,upgrade,Idexx Labs Price Target Raised to $610.00/Share From $550.00 by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $610.00/Share From $550.00 by Goldman Sachs
IDXX,2021-08-04,17:38:43,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Lane Registers 6,999 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Lane Registers 6,999 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-08-04,17:44:28,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Twigge Registers 8,874 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Twigge Registers 8,874 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-08-05,19:20:49,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,Vp Hunt Registers 538 Of IDEXX Laboratories Inc >IDXX,RNS-SEC144,Dow Jones Newswires,VP Hunt Registers 538 Of IDEXX Laboratories Inc >IDXX
IDXX,2021-08-05,19:53:49,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Twigge Registers 11,421 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Twigge Registers 11,421 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-08-05,21:03:51,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Lane Sells 6,999 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Lane Sells 6,999 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-08-05,21:05:24,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Twigge Sells 20,295 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Twigge Sells 20,295 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-08-09,21:03:20,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,Vp Hunt Sells 538 Of IDEXX Laboratories Inc,TABULAR-MATERIAL,Dow Jones Newswires,VP Hunt Sells 538 Of IDEXX Laboratories Inc >IDXX
IDXX,2021-08-09,21:03:30,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Ceo Mazelsky Acquires 206 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,CEO Mazelsky Acquires 206 Of IDEXX Laboratories Inc >IDXX
IDXX,2021-08-09,21:03:40,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Cfo McKeon Acquires 96 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,CFO McKeon Acquires 96 Of IDEXX Laboratories Inc >IDXX
IDXX,2021-08-09,21:03:55,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Szostak Sells 3,000 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Szostak Sells 3,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-08-11,19:11:31,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Junius Registers 2,402 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Junius Registers 2,402 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-08-12,21:01:28,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Vp Hunt Acquires 1,106 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"VP Hunt Acquires 1,106 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-08-12,21:02:28,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Junius Sells 2,402 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Junius Sells 2,402 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-08-13,11:10:54,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Outperform by Credit Suisse
IDXX,2021-08-13,11:10:54,B7EB38,IDEXX Laboratories Inc.,100,0.54,price-targets,upgrade,Idexx Labs Price Target Raised to $770.00/Share From $735.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $770.00/Share From $735.00 by Credit Suisse
IDXX,2021-08-16,19:17:33,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Ceo Mazelsky Registers 6,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"CEO Mazelsky Registers 6,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-08-17,21:05:08,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Ceo Mazelsky Sells 6,000 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mazelsky Sells 6,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-08-25,21:02:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,Vp Polewaczyk Gifts 522 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Polewaczyk Gifts 522 Of IDEXX Laboratories Inc >IDXX
IDXX,2021-08-31,18:56:32,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Turner Registers 3,776 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Turner Registers 3,776 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-08-31,21:02:40,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Turner Sells 2,000 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Turner Sells 2,000 Of IDEXX Laboratories Inc >IDXX-Amended"
IDXX,2021-08-31,21:02:49,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Turner Sells 2,526 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Turner Sells 2,526 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-09-02,21:07:00,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Vp Turner Acquires 1,256 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"VP Turner Acquires 1,256 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-10-08,20:15:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2021 Third Quarter Financial Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2021 Third Quarter Financial Results
IDXX,2021-10-08,20:15:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2021 Third Quarter Financial Results
IDXX,2021-10-08,20:15:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2021 Third Quarter Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2021 Third Quarter Financial Results
IDXX,2021-10-08,20:15:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2021 Third Quarter Financial Results
IDXX,2021-10-13,21:02:47,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Dir Claflin Acquires 1,921 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Claflin Acquires 1,921 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-10-23,08:13:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 3Q 2021 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories Inc, Inst Holders, 3Q 2021 (IDXX)"
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Third Quarter Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.63,revenues,up,IDEXX Laboratories Inc.: Achieves third quarter revenue growth of 12%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.03,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.62,revenues,up,IDEXX Laboratories Inc.: Average same-store revenue growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 9%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,-0.4,revenues,down,IDEXX Laboratories Inc.: LPD revenues declined 21%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 12%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 27.9% in the quarter,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,equity-actions,,IDEXX Laboratories Inc.: Operating expenses,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Third Quarter Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results -2-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact 1.5%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results -2-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results -2-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,94,-0.49,equity-actions,up,"IDEXX Laboratories Inc.: Operating expenses (as reported) $246,959 $250,750",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,94,0.62,earnings,up,IDEXX Laboratories Inc.: operating profit growth and comparable operating margin gain for the Company,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,IDEXX Laboratories Inc.: Comparable EPS,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,94,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2021 comparable EPS growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.51,products-services,,IDEXX Laboratories Inc.: we have deducted purchases of,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,96,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -5-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,94,0.0,equity-actions,,"IDEXX Laboratories Inc.: Cost of shares repurchased in the open market $183,315 $",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -6-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 3Q EPS $2.03,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 3Q EPS $2.03 >IDXX
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 3Q Net $175.2M,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 3Q Net $175.2M >IDXX
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs 3Q Rev $810.4M >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 3Q Rev $810.4M >IDXX
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Third Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.63,revenues,up,IDEXX Laboratories Inc.: Achieves third quarter revenue growth of 12%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.03,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.62,revenues,up,IDEXX Laboratories Inc.: Average same-store revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,-0.4,revenues,down,IDEXX Laboratories Inc.: LPD revenues declined 21%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 12%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 27.9% in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,equity-actions,,IDEXX Laboratories Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact 1.5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -2-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -2-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,94,-0.49,equity-actions,up,"IDEXX Laboratories Inc.: Operating expenses (as reported) $246,959 $250,750",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,94,0.62,earnings,up,IDEXX Laboratories Inc.: operating profit growth and comparable operating margin gain for the Company,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,IDEXX Laboratories Inc.: Comparable EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,94,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2021 comparable EPS growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.51,products-services,,IDEXX Laboratories Inc.: we have deducted purchases of,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,96,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -5-
IDXX,2021-11-02,10:30:10,B7EB38,IDEXX Laboratories Inc.,94,0.0,equity-actions,,"IDEXX Laboratories Inc.: Cost of shares repurchased in the open market $183,315 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -6-
IDXX,2021-11-02,10:34:57,B7EB38,IDEXX Laboratories Inc.,100,0.48,revenues,up,Idexx Labs Now Sees 2021 Revenue Up 17.5%-18%,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Now Sees 2021 Revenue Up 17.5%-18% >IDXX
IDXX,2021-11-02,10:35:16,B7EB38,IDEXX Laboratories Inc.,100,0.46,earnings,up,Idexx Labs Now Sees 2021 EPS Up 26%-27%,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Now Sees 2021 EPS Up 26%-27% on Comparable Basis >IDXX
IDXX,2021-11-02,10:36:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Labs Sees 2021 EPS $8.30,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2021 EPS $8.30-EPS $8.38 >IDXX
IDXX,2021-11-02,10:36:16,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs Sees 2021 Rev $3.185B-$3.2B >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2021 Rev $3.185B-$3.2B >IDXX
IDXX,2021-11-02,17:21:48,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories, Inc. CEO Jay Mazelsky on Q3 2021 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"IDEXX Laboratories, Inc. CEO Jay Mazelsky on Q3 2021 Results -- Earnings Call Transcript >IDXX"
IDXX,2021-11-02,17:21:48,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx-laboratories-inc-idxx-ceo-jay-mazelsky-on-q3-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,"IDEXX Laboratories, Inc. CEO Jay Mazelsky on Q3 2021 Results -- Earnings Call Transcript >IDXX"
IDXX,2021-11-10,20:26:50,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Cfo McKeon Registers 20,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"CFO McKeon Registers 20,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-11-10,22:33:56,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Cfo McKeon Sells 16,310 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CFO McKeon Sells 16,310 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-11-12,22:32:38,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Cfo McKeon Sells 20,000 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CFO McKeon Sells 20,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-11-12,22:47:48,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Cfo McKeon Registers 20,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"CFO McKeon Registers 20,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-11-15,22:13:56,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Cfo McKeon Sells 9,225 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CFO McKeon Sells 9,225 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-11-18,13:50:30,B7EB38,IDEXX Laboratories Inc.,100,0.95,analyst-ratings,positive,Idexx Labs Initiated at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Initiated at Overweight by Morgan Stanley
IDXX,2021-11-18,13:50:30,B7EB38,IDEXX Laboratories Inc.,100,0.0,price-targets,set,Idexx Labs Price Target Announced at $732.00/Share by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Announced at $732.00/Share by Morgan Stanley
IDXX,2021-12-01,22:02:35,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Polewaczyk Sells 4,595 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Polewaczyk Sells 4,595 Of IDEXX Laboratories Inc >IDXX"
IDXX,2021-12-09,22:55:22,B7EB38,IDEXX Laboratories Inc.,100,0.38,credit,,"Idexx Laboratories Gets $1B, Five-Year Revolving Credit Facility",RNS-SEC8K,Dow Jones Newswires,"IDEXX Laboratories Gets $1B, Five-Year Revolving Credit Facility >IDXX"
IDXX,2022-01-05,00:31:16,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,"Dir Ayers Gifts 6,961 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Gifts 6,961 Of IDEXX Laboratories Inc >IDXX"
IDXX,2022-01-11,20:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2021 Fourth Quarter and Full Year Financial Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2021 Fourth Quarter and Full Year Financial Results
IDXX,2022-01-11,20:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2021 Fourth Quarter and Full Year Financial Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2021 Fourth Quarter and Full Year Financial Results
IDXX,2022-01-11,20:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2021 Fourth Quarter and Full Year Financial Results
IDXX,2022-01-11,20:15:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2021 Fourth Quarter and Full Year Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2021 Fourth Quarter and Full Year Financial Results
IDXX,2022-01-11,20:15:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2021 Fourth Quarter and Full Year Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2021 Fourth Quarter and Full Year Financial Results
IDXX,2022-01-11,20:15:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2021 Fourth Quarter and Full Year Financial Results
IDXX,2022-01-13,14:00:04,B7EB38,IDEXX Laboratories Inc.,99,0.0,products-services,,IDEXX Laboratories Inc.: Results of this clinical validation study,PRESS-RELEASE,PR Newswire,"PetDx and IDEXX Expand Access to OncoK9, the Cancer Liquid Biopsy Test for Dogs"
IDXX,2022-01-13,14:00:04,B7EB38,IDEXX Laboratories Inc.,99,0.0,products-services,,IDEXX Laboratories Inc.: Results of this clinical validation study,PRESS-RELEASE,Dow Jones Newswires,"Press Release: PetDx and IDEXX Expand Access to OncoK9, the Cancer Liquid Biopsy Test for Dogs"
IDXX,2022-01-13,17:06:36,B7EB38,IDEXX Laboratories Inc.,100,0.49,partnerships,,Company Collaborates with IDEXX,PRESS-RELEASE,PR Newswire,One Health Company Collaborates with IDEXX to Expand Access to FidoCure(R) Precision Medicine Platform
IDXX,2022-01-23,09:20:17,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 4Q 2021 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories Inc, Inst Holders, 4Q 2021 (IDXX)"
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Fourth Quarter and Full Year 2021 Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Fourth Quarter and Full Year 2021 Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,"IDEXX Laboratories Inc.: For the full year 2021, EPS of $8.60",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Estimates 2022 EPS of $9.27 - $9.59,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company reports revenues of $801 million for the fourth quarter of 2021,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Earnings per diluted share,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,-0.4,revenues,down,"IDEXX Laboratories Inc.: For the full year 2021, LPD revenue decreased 9%",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.48,revenues,up,IDEXX Laboratories Inc.: The Company expects full year 2022 revenue growth of 9% - 11%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.62,revenues,up,IDEXX Laboratories Inc.: Average same-store revenue growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.65,revenues,up,IDEXX Laboratories Inc.: Revenue growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 12%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 24.9% in the quarter,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,-0.26,equity-actions,up,IDEXX Laboratories Inc.: Operating expenses increased 15%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.65,revenues,up,"IDEXX Laboratories Inc.: Revenue $3,500 -$3,565",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -2-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will host a conference call today at 8:30 a.m.",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -2-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 4Q EPS $1.89,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 4Q EPS $1.89 >IDXX
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,96,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -3-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,96,-0.49,equity-actions,up,"IDEXX Laboratories Inc.: Operating expenses (as reported) $ 257,230 $224,407",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -3-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,96,0.62,earnings,up,IDEXX Laboratories Inc.: operating profit growth and comparable operating margin gain for the Company,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -3-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,96,0.0,earnings,,IDEXX Laboratories Inc.: Comparable EPS,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -3-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 4Q Net $162.8M,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 4Q Net $162.8M >IDXX
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs 4Q Rev $801.1M >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 4Q Rev $801.1M >IDXX
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Comparable EPS,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2022 comparable EPS growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.53,labor-issues,,IDEXX Laboratories Inc.: CEO transition,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,-0.57,labor-issues,,"IDEXX Laboratories Inc.: our former Chairman of the Board, President and Chief Executive Officer, stepped down",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,95,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -5-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,98,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -6-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,98,0.0,equity-actions,,"IDEXX Laboratories Inc.: Cost of shares repurchased in the open market $244,608 $",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -6-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Fourth Quarter and Full Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Fourth Quarter and Full Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,"IDEXX Laboratories Inc.: For the full year 2021, EPS of $8.60",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Estimates 2022 EPS of $9.27 - $9.59,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company reports revenues of $801 million for the fourth quarter of 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Earnings per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,-0.4,revenues,down,"IDEXX Laboratories Inc.: For the full year 2021, LPD revenue decreased 9%",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.48,revenues,up,IDEXX Laboratories Inc.: The Company expects full year 2022 revenue growth of 9% - 11%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.62,revenues,up,IDEXX Laboratories Inc.: Average same-store revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.65,revenues,up,IDEXX Laboratories Inc.: Revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 12%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 24.9% in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,-0.26,equity-actions,up,IDEXX Laboratories Inc.: Operating expenses increased 15%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.65,revenues,up,"IDEXX Laboratories Inc.: Revenue $3,500 -$3,565",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -2-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will host a conference call today at 8:30 a.m.",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -2-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,96,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,96,-0.49,equity-actions,up,"IDEXX Laboratories Inc.: Operating expenses (as reported) $ 257,230 $224,407",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,96,0.62,earnings,up,IDEXX Laboratories Inc.: operating profit growth and comparable operating margin gain for the Company,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,96,0.0,earnings,,IDEXX Laboratories Inc.: Comparable EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Comparable EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2022 comparable EPS growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.53,labor-issues,,IDEXX Laboratories Inc.: CEO transition,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,-0.57,labor-issues,,"IDEXX Laboratories Inc.: our former Chairman of the Board, President and Chief Executive Officer, stepped down",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,95,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -5-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,98,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -6-
IDXX,2022-02-02,11:30:08,B7EB38,IDEXX Laboratories Inc.,98,0.0,equity-actions,,"IDEXX Laboratories Inc.: Cost of shares repurchased in the open market $244,608 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -6-
IDXX,2022-02-02,11:39:46,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs Sees 2022 Rev $3.5B-$3.565B >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2022 Rev $3.5B-$3.565B >IDXX
IDXX,2022-02-02,11:40:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Labs Sees 2022 EPS $9.27,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2022 EPS $9.27-EPS $9.59 >IDXX
IDXX,2022-02-02,11:41:59,B7EB38,IDEXX Laboratories Inc.,100,0.65,revenues,up,Idexx Posts Higher 4Q Rev,FULL-ARTICLE,Dow Jones Newswires,Idexx Posts Higher 4Q Rev But Lower Earnings
IDXX,2022-02-02,11:41:59,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx reported comparable earnings per share of $1.83,FULL-ARTICLE,Dow Jones Newswires,Idexx Posts Higher 4Q Rev But Lower Earnings
IDXX,2022-02-02,11:44:03,B7EB38,IDEXX Laboratories Inc.,91,0.0,revenues,,Idexx Laboratories Inc. Wednesday issued 2022 earnings and revenue guidance,FULL-ARTICLE,Dow Jones Newswires,Idexx Eyes 2022 Results Ahead of Analysts' Forecasts
IDXX,2022-02-02,12:41:31,B7EB38,IDEXX Laboratories Inc.,92,0.0,revenues,,Idexx Laboratories Inc. will post revenue of $3.53 billion,FULL-ARTICLE,Dow Jones Newswires,Correction to Idexx Guidance Article
IDXX,2022-02-02,17:46:33,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories, Inc. CEO Jay Mazelsky on Q4 2021 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"IDEXX Laboratories, Inc. CEO Jay Mazelsky on Q4 2021 Results -- Earnings Call Transcript >IDXX"
IDXX,2022-02-02,17:46:33,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx-laboratories-inc-idxx-ceo-jay-mazelsky-on-q4-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,"IDEXX Laboratories, Inc. CEO Jay Mazelsky on Q4 2021 Results -- Earnings Call Transcript >IDXX"
IDXX,2022-02-05,09:13:18,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories, Inc. CEO Jay Mazelsky on Q4 2021 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"IDEXX Laboratories, Inc. CEO Jay Mazelsky on Q4 2021 Results -- Earnings Call Transcript >IDXX"
IDXX,2022-02-05,09:13:18,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx-laboratories-inc-idxx-ceo-jay-mazelsky-on-q4-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,"IDEXX Laboratories, Inc. CEO Jay Mazelsky on Q4 2021 Results -- Earnings Call Transcript >IDXX"
IDXX,2022-02-08,11:22:01,B7EB38,IDEXX Laboratories Inc.,100,0.95,analyst-ratings,positive,Idexx Labs Initiated at Overweight by Atlantic Equities,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Initiated at Overweight by Atlantic Equities
IDXX,2022-02-08,11:22:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,price-targets,set,Idexx Labs Price Target Announced at $650.00/Share by Atlantic Equities,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Announced at $650.00/Share by Atlantic Equities
IDXX,2022-02-17,00:24:59,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Hunt Acquires 471 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Hunt Acquires 471 Of IDEXX Laboratories Inc >IDXX
IDXX,2022-02-17,00:26:15,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Ceo Mazelsky Acquires 1,640 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mazelsky Acquires 1,640 Of IDEXX Laboratories Inc >IDXX"
IDXX,2022-02-17,00:27:06,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Cfo McKeon Acquires 1,121 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"CFO McKeon Acquires 1,121 Of IDEXX Laboratories Inc >IDXX"
IDXX,2022-02-17,00:28:15,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Polewaczyk Acquires 546 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Polewaczyk Acquires 546 Of IDEXX Laboratories Inc >IDXX
IDXX,2022-02-17,00:29:34,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Turner Acquires 556 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Turner Acquires 556 Of IDEXX Laboratories Inc >IDXX
IDXX,2022-02-17,00:30:23,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Twigge Acquires 583 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Twigge Acquires 583 Of IDEXX Laboratories Inc >IDXX
IDXX,2022-02-17,00:30:56,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Underberg Acquires 585 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Underberg Acquires 585 Of IDEXX Laboratories Inc >IDXX
IDXX,2022-02-17,20:00:05,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Two Upcoming Institutional Investor Conferences,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
IDXX,2022-02-17,20:00:05,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Two Upcoming Institutional Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
IDXX,2022-02-17,20:35:38,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,Dir Ayers Registers 250 Of IDEXX Laboratories Inc >IDXX,RNS-SEC144,Dow Jones Newswires,Dir Ayers Registers 250 Of IDEXX Laboratories Inc >IDXX
IDXX,2022-02-17,22:50:13,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,Dir Ayers Sells 250 Of IDEXX Laboratories Inc,TABULAR-MATERIAL,Dow Jones Newswires,Dir Ayers Sells 250 Of IDEXX Laboratories Inc >IDXX
IDXX,2022-02-17,22:51:10,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Cfo McKeon Acquires 706 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,CFO McKeon Acquires 706 Of IDEXX Laboratories Inc >IDXX
IDXX,2022-02-18,22:04:38,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Underberg Acquires 483 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Underberg Acquires 483 Of IDEXX Laboratories Inc >IDXX
IDXX,2022-02-22,22:05:36,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Vp Turner Acquires 2,180 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"VP Turner Acquires 2,180 Of IDEXX Laboratories Inc >IDXX"
IDXX,2022-02-22,22:10:36,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Dir Ayers Acquires 706 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,Dir Ayers Acquires 706 Of IDEXX Laboratories Inc >IDXX
IDXX,2022-02-25,23:02:57,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Vp Twigge Acquires 2,599 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"VP Twigge Acquires 2,599 Of IDEXX Laboratories Inc >IDXX"
IDXX,2022-03-07,22:01:35,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,Ceo Mazelsky Gifts 500 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,CEO Mazelsky Gifts 500 Of IDEXX Laboratories Inc >IDXX
IDXX,2022-04-11,19:00:04,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2022 First Quarter Financial Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2022 First Quarter Financial Results
IDXX,2022-04-11,19:00:04,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2022 First Quarter Financial Results
IDXX,2022-04-11,19:00:04,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2022 First Quarter Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2022 First Quarter Financial Results
IDXX,2022-04-11,19:00:04,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2022 First Quarter Financial Results
IDXX,2022-04-24,07:39:45,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 1Q 2022 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories Inc, Inst Holders, 1Q 2022 (IDXX)"
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces First Quarter Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,"IDEXX Laboratories Inc.: The Company reports revenues of $837 million for the first quarter of 2022, an 8% increase",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.27,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Adjusts 2022 guidance,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: First quarter earnings per diluted share,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.62,revenues,up,IDEXX Laboratories Inc.: Average same-store revenue growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 7%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,-0.4,revenues,down,IDEXX Laboratories Inc.: LPD revenues declined 21%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 6%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 29.7% in the quarter,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,-0.2,equity-actions,up,IDEXX Laboratories Inc.: Operating expenses increased 12%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company now projects full year operating margins of 26.8% - 27.3%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 1Q EPS $2.27,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 1Q EPS $2.27 >IDXX
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces First Quarter Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact (2.5%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: 2022 Annual Meeting,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 1Q Net $194M,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 1Q Net $194M >IDXX
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,-0.49,equity-actions,up,"IDEXX Laboratories Inc.: Operating expenses (as reported) $ 250,409 $ 223,160",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.62,earnings,up,IDEXX Laboratories Inc.: operating profit growth and comparable operating margin gain for the Company,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.64,earnings,up,IDEXX Laboratories Inc.: Comparable EPS growth $ 2.24 $ 2.18,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2022 comparable EPS growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs 1Q Rev $836.5M >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 1Q Rev $836.5M >IDXX
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.51,products-services,,IDEXX Laboratories Inc.: we have deducted purchases of,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.0,assets,,"IDEXX Laboratories Inc.: March 31, December 31, 2022 2021 Assets",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,96,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -5-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,96,0.59,equity-actions,,IDEXX Laboratories Inc.: Repurchases of common stock,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -5-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,96,0.0,equity-actions,,"IDEXX Laboratories Inc.: Cost of shares repurchased in the open market $262,783 $139,213",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces First Quarter -5-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx's first quarter results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,"IDEXX Laboratories Inc.: The Company reports revenues of $837 million for the first quarter of 2022, an 8% increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.27,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Adjusts 2022 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: First quarter earnings per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.62,revenues,up,IDEXX Laboratories Inc.: Average same-store revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 7%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,-0.4,revenues,down,IDEXX Laboratories Inc.: LPD revenues declined 21%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 6%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 29.7% in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,-0.2,equity-actions,up,IDEXX Laboratories Inc.: Operating expenses increased 12%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company now projects full year operating margins of 26.8% - 27.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact (2.5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -2-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -2-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,IDEXX Laboratories Inc.: 2022 Annual Meeting,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -2-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,-0.49,equity-actions,up,"IDEXX Laboratories Inc.: Operating expenses (as reported) $ 250,409 $ 223,160",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.62,earnings,up,IDEXX Laboratories Inc.: operating profit growth and comparable operating margin gain for the Company,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.64,earnings,up,IDEXX Laboratories Inc.: Comparable EPS growth $ 2.24 $ 2.18,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2022 comparable EPS growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.51,products-services,,IDEXX Laboratories Inc.: we have deducted purchases of,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,99,0.0,assets,,"IDEXX Laboratories Inc.: March 31, December 31, 2022 2021 Assets",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,96,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -5-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,96,0.59,equity-actions,,IDEXX Laboratories Inc.: Repurchases of common stock,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -5-
IDXX,2022-05-04,10:30:10,B7EB38,IDEXX Laboratories Inc.,96,0.0,equity-actions,,"IDEXX Laboratories Inc.: Cost of shares repurchased in the open market $262,783 $139,213",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -5-
IDXX,2022-05-04,10:37:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Labs Sees 2022 EPS $8.11,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2022 EPS $8.11-EPS $8.35 >IDXX
IDXX,2022-05-04,10:37:44,B7EB38,IDEXX Laboratories Inc.,100,0.48,revenues,up,Idexx Labs Now Sees 2022 Revenue Up 5.5%-8%,NEWS-FLASH,Dow Jones Newswires,"IDEXX Labs Now Sees 2022 Revenue Up 5.5%-8%, Organic Revenue Up 7.5%-10% >IDXX"
IDXX,2022-05-04,13:06:56,B7EB38,IDEXX Laboratories Inc.,96,-0.74,earnings,down,IDEXX Laboratories Inc.: the company lowered its guidance,FULL-ARTICLE,Dow Jones Newswires,IDEXX Laboratories Shares Slide Premarket After Guidance Cut
IDXX,2022-05-04,13:06:56,B7EB38,IDEXX Laboratories Inc.,96,0.0,earnings,,Idexx issued an EPS,FULL-ARTICLE,Dow Jones Newswires,IDEXX Laboratories Shares Slide Premarket After Guidance Cut
IDXX,2022-05-04,13:06:56,B7EB38,IDEXX Laboratories Inc.,96,0.41,revenues,up,"IDEXX Laboratories Inc.: The company reported first-quarter revenue of $836.5 million, up 8%",FULL-ARTICLE,Dow Jones Newswires,IDEXX Laboratories Shares Slide Premarket After Guidance Cut
IDXX,2022-05-04,15:49:45,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories, Inc. CEO Jonathan Mazelsky on Q1 2022 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"IDEXX Laboratories, Inc. CEO Jonathan Mazelsky on Q1 2022 Results -- Earnings Call Transcript >IDXX"
IDXX,2022-05-04,15:49:45,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx-laboratories-inc-idxx-ceo-jonathan-mazelsky-on-q1-2022-results-earnings,NEWS-FLASH,Dow Jones Newswires,"IDEXX Laboratories, Inc. CEO Jonathan Mazelsky on Q1 2022 Results -- Earnings Call Transcript >IDXX"
IDXX,2022-05-05,10:36:39,B7EB38,IDEXX Laboratories Inc.,100,-0.58,analyst-ratings,negative,Idexx Labs Cut to Neutral From Buy,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Cut to Neutral From Buy by B of A Securities
IDXX,2022-05-05,10:36:39,B7EB38,IDEXX Laboratories Inc.,100,-0.8,price-targets,downgrade,Idexx Labs Price Target Cut to $470.00/Share From $550.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $470.00/Share From $550.00 by B of A Securities
IDXX,2022-05-05,12:34:19,B7EB38,IDEXX Laboratories Inc.,100,-0.82,price-targets,downgrade,Idexx Laboratories stock price target cut to $575 from $700 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW IDEXX Laboratories stock price target cut to $575 from $700 at Stifel Nicolaus
IDXX,2022-05-05,13:28:20,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Morgan Stanley
IDXX,2022-05-05,13:28:20,B7EB38,IDEXX Laboratories Inc.,100,-0.82,price-targets,downgrade,Idexx Labs Price Target Cut to $603.00/Share From $732.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $603.00/Share From $732.00 by Morgan Stanley
IDXX,2022-05-18,18:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Stifel Conference,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day
IDXX,2022-05-18,18:30:04,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Stifel Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day
IDXX,2022-05-19,11:52:38,B7EB38,IDEXX Laboratories Inc.,100,0.0,analyst-ratings,neutral,Idexx Labs Is Maintained at Neutral by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Neutral by Goldman Sachs
IDXX,2022-05-19,11:52:38,B7EB38,IDEXX Laboratories Inc.,100,-0.8,price-targets,downgrade,Idexx Labs Price Target Cut to $530.00/Share From $615.00 by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $530.00/Share From $615.00 by Goldman Sachs
IDXX,2022-05-23,21:07:14,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Ceo Mazelsky Acquires 706 Of IDEXX Laboratories Inc >IDXX,FULL-ARTICLE,Dow Jones Newswires,CEO Mazelsky Acquires 706 Of IDEXX Laboratories Inc >IDXX
IDXX,2022-05-26,19:54:22,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Twigge Registers 1,250 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Twigge Registers 1,250 Of IDEXX Laboratories Inc >IDXX"
IDXX,2022-06-24,10:42:49,B7EB38,IDEXX Laboratories Inc.,100,-0.8,price-targets,downgrade,Idexx Laboratories stock price target cut to $500 from $575 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW IDEXX Laboratories stock price target cut to $500 from $575 at Stifel Nicolaus
IDXX,2022-06-24,12:20:32,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Buy by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Buy by Stifel
IDXX,2022-06-24,12:20:32,B7EB38,IDEXX Laboratories Inc.,100,-0.8,price-targets,downgrade,Idexx Labs Price Target Cut to $500.00/Share From $575.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $500.00/Share From $575.00 by Stifel
IDXX,2022-07-08,18:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2022 Second Quarter Financial Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2022 Second Quarter Financial Results
IDXX,2022-07-08,18:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2022 Second Quarter Financial Results
IDXX,2022-07-08,18:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2022 Second Quarter Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2022 Second Quarter Financial Results
IDXX,2022-07-08,18:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2022 Second Quarter Financial Results
IDXX,2022-07-12,09:41:23,B7EB38,IDEXX Laboratories Inc.,100,0.95,analyst-ratings,positive,Idexx Labs Initiated at Overweight by Piper Sandler,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Initiated at Overweight by Piper Sandler
IDXX,2022-07-12,09:41:23,B7EB38,IDEXX Laboratories Inc.,100,0.0,price-targets,set,Idexx Labs Price Target Announced at $440.00/Share by Piper Sandler,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Announced at $440.00/Share by Piper Sandler
IDXX,2022-07-21,10:07:50,B7EB38,IDEXX Laboratories Inc.,100,0.94,analyst-ratings,positive,Idexx Labs Raised to Buy From Neutral by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Raised to Buy From Neutral by Goldman Sachs
IDXX,2022-07-21,10:07:50,B7EB38,IDEXX Laboratories Inc.,100,-0.82,price-targets,downgrade,Idexx Labs Price Target Cut to $435.00/Share From $530.00 by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $435.00/Share From $530.00 by Goldman Sachs
IDXX,2022-07-24,07:38:46,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 2Q 2022 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories Inc, Inst Holders, 2Q 2022 (IDXX)"
IDXX,2022-07-25,11:21:44,B7EB38,IDEXX Laboratories Inc.,100,-0.58,analyst-ratings,negative,Idexx Laboratories downgraded to hold from buy at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Idexx Laboratories downgraded to hold from buy at Stifel Nicolaus
IDXX,2022-07-25,12:06:05,B7EB38,IDEXX Laboratories Inc.,100,-0.58,analyst-ratings,negative,Idexx Labs Cut to Hold From Buy by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Cut to Hold From Buy by Stifel
IDXX,2022-07-25,12:06:05,B7EB38,IDEXX Laboratories Inc.,100,-0.82,price-targets,downgrade,Idexx Labs Price Target Cut to $415.00/Share From $500.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $415.00/Share From $500.00 by Stifel
IDXX,2022-07-26,10:56:01,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Piper Sandler,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Piper Sandler
IDXX,2022-07-26,10:56:01,B7EB38,IDEXX Laboratories Inc.,100,-0.56,price-targets,downgrade,Idexx Labs Price Target Cut to $420.00/Share From $440.00 by Piper Sandler,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $420.00/Share From $440.00 by Piper Sandler
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Second Quarter Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,"IDEXX Laboratories Inc.: The Company reports revenues of $861 million for the second quarter of 2022, a 4% increase",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $1.56,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Adjusts 2022 revenue,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Second quarter earnings per diluted share,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 4%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,-0.24,revenues,down,IDEXX Laboratories Inc.: LPD revenues declined 11%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 5%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 20.8% in the quarter,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.0,equity-actions,,IDEXX Laboratories Inc.: Operating expense,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company now projects full year operating margins of 26.4% - 26.9%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact (3.0 %,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -2-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -2-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,-0.49,equity-actions,up,"IDEXX Laboratories Inc.: Operating expenses (as reported) $ 334,966 $ 230,055",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.62,earnings,up,IDEXX Laboratories Inc.: operating profit growth and comparable operating margin gain for the Company,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Comparable EPS,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2022 comparable EPS growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.51,products-services,,IDEXX Laboratories Inc.: we have deducted purchases of,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,96,0.0,revenues,,"IDEXX Laboratories Inc.: revenue: $685,413 $661,300",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -5-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,96,0.0,assets,,"IDEXX Laboratories Inc.: June 30, December 31, 2022 2021 Assets",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -5-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,93,0.0,equity-actions,,"IDEXX Laboratories Inc.: Cost of shares repurchased in the open market $ 313,455 $ 188,409 $",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Second Quarter -6-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 2Q EPS $1.56,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 2Q EPS $1.56 >IDXX
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 2Q Net $132M,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 2Q Net $132M >IDXX
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs 2Q Rev $860.5M >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 2Q Rev $860.5M >IDXX
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Second Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,"IDEXX Laboratories Inc.: The Company reports revenues of $861 million for the second quarter of 2022, a 4% increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $1.56,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Adjusts 2022 revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Second quarter earnings per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 4%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,-0.24,revenues,down,IDEXX Laboratories Inc.: LPD revenues declined 11%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 20.8% in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.0,equity-actions,,IDEXX Laboratories Inc.: Operating expense,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company now projects full year operating margins of 26.4% - 26.9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact (3.0 %,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -2-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -2-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,-0.49,equity-actions,up,"IDEXX Laboratories Inc.: Operating expenses (as reported) $ 334,966 $ 230,055",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.62,earnings,up,IDEXX Laboratories Inc.: operating profit growth and comparable operating margin gain for the Company,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Comparable EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2022 comparable EPS growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.51,products-services,,IDEXX Laboratories Inc.: we have deducted purchases of,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,96,0.0,assets,,"IDEXX Laboratories Inc.: June 30, December 31, 2022 2021 Assets",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -5-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,96,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -5-
IDXX,2022-08-02,10:30:11,B7EB38,IDEXX Laboratories Inc.,93,0.0,equity-actions,,"IDEXX Laboratories Inc.: Cost of shares repurchased in the open market $ 313,455 $ 188,409 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -6-
IDXX,2022-08-02,10:40:06,B7EB38,IDEXX Laboratories Inc.,100,0.48,revenues,up,Idexx Labs Now Sees 2022 Revenue Up 3%-5.5%,NEWS-FLASH,Dow Jones Newswires,"IDEXX Labs Now Sees 2022 Revenue Up 3%-5.5%, Organic Rev Up 5.5%-8% >IDXX"
IDXX,2022-08-02,10:40:33,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Labs Sees 2022 EPS $7.77,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2022 EPS $7.77-EPS $8.05 >IDXX
IDXX,2022-08-02,14:04:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories, Inc. CEO Jay Mazelsky on Q2 2022 Results -- Earnings Call Transcript",NEWS-FLASH,Dow Jones Newswires,"IDEXX Laboratories, Inc. CEO Jay Mazelsky on Q2 2022 Results -- Earnings Call Transcript >IDXX"
IDXX,2022-08-02,14:04:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx-laboratories-inc-idxx-ceo-jay-mazelsky-on-q2-2022-results-earnings,NEWS-FLASH,Dow Jones Newswires,"IDEXX Laboratories, Inc. CEO Jay Mazelsky on Q2 2022 Results -- Earnings Call Transcript >IDXX"
IDXX,2022-08-03,08:49:41,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Atlantic Equities,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Atlantic Equities
IDXX,2022-08-03,08:49:41,B7EB38,IDEXX Laboratories Inc.,100,-0.38,price-targets,downgrade,Idexx Labs Price Target Cut to $490.00/Share From $500.00 by Atlantic Equities,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $490.00/Share From $500.00 by Atlantic Equities
IDXX,2022-08-04,14:07:29,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Morgan Stanley
IDXX,2022-08-04,14:07:29,B7EB38,IDEXX Laboratories Inc.,100,-0.6,price-targets,downgrade,Idexx Labs Price Target Cut to $573.00/Share From $603.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $573.00/Share From $603.00 by Morgan Stanley
IDXX,2022-08-05,11:57:05,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Barclays,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Barclays
IDXX,2022-08-05,11:57:05,B7EB38,IDEXX Laboratories Inc.,100,-0.82,price-targets,downgrade,Idexx Labs Price Target Cut to $582.00/Share From $700.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $582.00/Share From $700.00 by Barclays
IDXX,2022-08-08,21:02:52,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Ceo Mazelsky Acquires 206 Of IDEXX Laboratories Inc >IDXX,FULL-ARTICLE,Dow Jones Newswires,CEO Mazelsky Acquires 206 Of IDEXX Laboratories Inc >IDXX
IDXX,2022-08-08,21:03:37,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Cfo McKeon Acquires 102 Of IDEXX Laboratories Inc >IDXX,FULL-ARTICLE,Dow Jones Newswires,CFO McKeon Acquires 102 Of IDEXX Laboratories Inc >IDXX
IDXX,2022-09-06,21:01:50,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Smith Acquires 13 Of IDEXX Laboratories Inc >IDXX,FULL-ARTICLE,Dow Jones Newswires,VP Smith Acquires 13 Of IDEXX Laboratories Inc >IDXX
IDXX,2022-09-08,21:01:26,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,"Dir Ayers Gifts 455,000 Of IDEXX Laboratories Inc >IDXX",FULL-ARTICLE,Dow Jones Newswires,"Dir Ayers Gifts 455,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2022-10-11,19:15:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2022 Third Quarter Financial Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2022 Third Quarter Financial Results
IDXX,2022-10-11,19:15:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2022 Third Quarter Financial Results
IDXX,2022-10-11,19:15:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2022 Third Quarter Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2022 Third Quarter Financial Results
IDXX,2022-10-11,19:15:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2022 Third Quarter Financial Results
IDXX,2022-10-17,12:57:26,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by JP Morgan
IDXX,2022-10-17,12:57:27,B7EB38,IDEXX Laboratories Inc.,100,-0.8,price-targets,downgrade,Idexx Labs Price Target Cut to $450.00/Share From $525.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $450.00/Share From $525.00 by JP Morgan
IDXX,2022-10-24,07:26:20,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 3Q 2022 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories Inc, Inst Holders, 3Q 2022 (IDXX)"
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 3Q EPS $2.15,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 3Q EPS $2.15 >IDXX
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Third Quarter Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,"IDEXX Laboratories Inc.: The Company reports revenues of $842 million for the third quarter of 2022, a 4% increase",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.15,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Average U.S. diagnostics revenue,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Third quarter earnings per diluted share,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 5%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,100,-0.24,revenues,down,IDEXX Laboratories Inc.: LPD revenues declined 2%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 7%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 29.1% in the quarter,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,100,-0.49,equity-actions,up,"IDEXX Laboratories Inc.: As planned, operating expense growth",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company updated its full-year reported operating margin outlook,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Third Quarter Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results -2-
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact ( 4%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results -2-
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter Results -2-
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 3Q Net $180.9M,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 3Q Net $180.9M >IDXX
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,97,-0.49,equity-actions,up,"IDEXX Laboratories Inc.: Operating expenses (as reported) $ 261,798 $ 246,959",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,97,0.62,earnings,up,IDEXX Laboratories Inc.: operating profit growth and comparable operating margin gain for the Company,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.15 $ 2.03,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,97,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2022 comparable EPS growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,97,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,97,0.51,products-services,,IDEXX Laboratories Inc.: we have deducted purchases of,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs 3Q Rev $841.7M >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 3Q Rev $841.7M >IDXX
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,98,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $841,661 $810,421",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,98,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 506,626",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,98,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,98,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $2.15 $2.03,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,94,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $2,640,067 $2,437,203",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -6-
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,94,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -6-
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,94,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -6-
IDXX,2022-11-01,10:30:06,B7EB38,IDEXX Laboratories Inc.,94,0.0,equity-actions,,"IDEXX Laboratories Inc.: Cost of shares repurchased in the open market $ 166,423 $ 183,315 $",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Third Quarter -6-
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Third Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,"IDEXX Laboratories Inc.: The Company reports revenues of $842 million for the third quarter of 2022, a 4% increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Average U.S. diagnostics revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Third quarter earnings per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,100,-0.24,revenues,down,IDEXX Laboratories Inc.: LPD revenues declined 2%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 7%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 29.1% in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,100,-0.49,equity-actions,up,"IDEXX Laboratories Inc.: As planned, operating expense growth",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company updated its full-year reported operating margin outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact ( 4%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -2-
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -2-
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,97,-0.49,equity-actions,up,"IDEXX Laboratories Inc.: Operating expenses (as reported) $ 261,798 $ 246,959",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,97,0.62,earnings,up,IDEXX Laboratories Inc.: operating profit growth and comparable operating margin gain for the Company,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.15 $ 2.03,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,97,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2022 comparable EPS growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,97,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,97,0.51,products-services,,IDEXX Laboratories Inc.: we have deducted purchases of,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,98,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $841,661 $810,421",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,98,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 506,626",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,98,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,98,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $2.15 $2.03,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,94,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $2,640,067 $2,437,203",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -6-
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,94,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -6-
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,94,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -6-
IDXX,2022-11-01,10:30:22,B7EB38,IDEXX Laboratories Inc.,94,0.0,equity-actions,,"IDEXX Laboratories Inc.: Cost of shares repurchased in the open market $ 166,423 $ 183,315 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -6-
IDXX,2022-11-01,10:34:27,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs Adjusts 2022 Rev Guidance,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Adjusts 2022 Rev Guidance to 3.5%-4.5% Growth >IDXX
IDXX,2022-11-01,10:35:11,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Labs Adjusts 2022 View,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Adjusts 2022 View To EPS $7.74-EPS $7.98 >IDXX
IDXX,2022-11-01,10:56:19,B7EB38,IDEXX Laboratories Inc.,100,0.64,earnings,up,"Idexx Laboratories 3Q Profit, Revenue Rise",FULL-ARTICLE,Dow Jones Newswires,"IDEXX Laboratories 3Q Profit, Revenue Rise on Companion Animal Group Diagnostics Unit"
IDXX,2022-11-01,14:33:00,B7EB38,IDEXX Laboratories Inc.,100,0.7,earnings,above-expectations,"Idexx Laboratories reported earnings per share of $2.15, above market views",FULL-ARTICLE,Dow Jones Newswires,IDEXX Laboratories Stock Climbs 10% as It Beats 3Q Market Views
IDXX,2022-11-02,10:15:20,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Atlantic Equities,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Atlantic Equities
IDXX,2022-11-02,10:15:20,B7EB38,IDEXX Laboratories Inc.,100,-0.52,price-targets,downgrade,Idexx Labs Price Target Cut to $470.00/Share From $490.00 by Atlantic Equities,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $470.00/Share From $490.00 by Atlantic Equities
IDXX,2022-11-08,20:54:33,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Ceo Mazelsky Registers 13,230 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"CEO Mazelsky Registers 13,230 Of IDEXX Laboratories Inc >IDXX"
IDXX,2022-11-09,22:02:28,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Ceo Mazelsky Sells 13,230 Of IDEXX Laboratories Inc",FULL-ARTICLE,Dow Jones Newswires,"CEO Mazelsky Sells 13,230 Of IDEXX Laboratories Inc >IDXX"
IDXX,2022-11-14,22:02:34,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Turner Sells 13,877 Of IDEXX Laboratories Inc",FULL-ARTICLE,Dow Jones Newswires,"VP Turner Sells 13,877 Of IDEXX Laboratories Inc >IDXX"
IDXX,2022-11-15,13:47:41,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Morgan Stanley
IDXX,2022-11-15,13:47:41,B7EB38,IDEXX Laboratories Inc.,100,-0.6,price-targets,downgrade,Idexx Labs Price Target Cut to $543.00/Share From $573.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $543.00/Share From $573.00 by Morgan Stanley
IDXX,2022-11-15,17:00:26,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Turner Registers 5,310 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Turner Registers 5,310 Of IDEXX Laboratories Inc >IDXX"
IDXX,2022-11-15,19:39:43,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Turner Registers 8,567 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Turner Registers 8,567 Of IDEXX Laboratories Inc >IDXX"
IDXX,2022-11-15,21:15:35,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Ceo Mazelsky Registers 10,500 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"CEO Mazelsky Registers 10,500 Of IDEXX Laboratories Inc >IDXX"
IDXX,2022-11-16,22:02:41,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Ceo Mazelsky Sells 10,500 Of IDEXX Laboratories Inc",FULL-ARTICLE,Dow Jones Newswires,"CEO Mazelsky Sells 10,500 Of IDEXX Laboratories Inc >IDXX"
IDXX,2022-12-05,18:51:45,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Turner Registers 3,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Turner Registers 3,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2022-12-05,22:01:16,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Turner Sells 3,000 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Turner Sells 3,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2022-12-05,22:03:45,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,Dir Szostak Registers 740 Of IDEXX Laboratories Inc >IDXX,RNS-SEC144,Dow Jones Newswires,Dir Szostak Registers 740 Of IDEXX Laboratories Inc >IDXX
IDXX,2022-12-06,21:09:59,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Junius Registers 3,046 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Junius Registers 3,046 Of IDEXX Laboratories Inc >IDXX"
IDXX,2022-12-06,22:05:15,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,Dir Szostak Sells 740 Of IDEXX Laboratories Inc,TABULAR-MATERIAL,Dow Jones Newswires,Dir Szostak Sells 740 Of IDEXX Laboratories Inc >IDXX
IDXX,2022-12-06,22:08:49,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,"Dir Ayers Gifts 7,400 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Gifts 7,400 Of IDEXX Laboratories Inc >IDXX"
IDXX,2022-12-07,21:31:51,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Junius Sells 3,046 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Junius Sells 3,046 Of IDEXX Laboratories Inc >IDXX"
IDXX,2022-12-22,19:36:07,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
IDXX,2023-01-12,13:29:46,B7EB38,IDEXX Laboratories Inc.,99,0.39,products-services,,IDEXX Laboratories Inc.: our previously announced supply agreement,PRESS-RELEASE,PR Newswire,Volition Announces Expansion of Availability of the Nu.Q(R) Vet Cancer Test Through IDEXX's Reference Laboratory Network
IDXX,2023-01-12,13:33:35,B7EB38,IDEXX Laboratories Inc.,99,0.39,products-services,,IDEXX Laboratories Inc.: our previously announced supply agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Volition Announces Expansion of Availability of the Nu.Q(R) Vet Cancer Test Through IDEXX's Reference Laboratory Network
IDXX,2023-01-23,09:18:20,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 4Q 2022 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories Inc, Inst Holders, 4Q 2022 (IDXX)"
IDXX,2023-01-25,12:59:09,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Buy by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Buy by Goldman Sachs
IDXX,2023-01-25,12:59:09,B7EB38,IDEXX Laboratories Inc.,100,0.78,price-targets,upgrade,Idexx Labs Price Target Raised to $530.00/Share From $465.00 by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $530.00/Share From $465.00 by Goldman Sachs
IDXX,2023-01-26,13:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2022 Fourth Quarter and Full Year Financial Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2022 Fourth Quarter and Full Year Financial Results
IDXX,2023-01-26,13:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2022 Fourth Quarter and Full Year Financial Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2022 Fourth Quarter and Full Year Financial Results
IDXX,2023-01-26,13:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Release 2022 Fourth Quarter and Full Year Financial Results
IDXX,2023-01-26,13:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2022 Fourth Quarter and Full Year Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2022 Fourth Quarter and Full Year Financial Results
IDXX,2023-01-26,13:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2022 Fourth Quarter and Full Year Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2022 Fourth Quarter and Full Year Financial Results
IDXX,2023-01-26,13:15:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2022 Fourth Quarter and Full Year Financial Results
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 4Q EPS $2.05,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 4Q EPS $2.05 >IDXX
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Fourth Quarter and Full Year 2022 Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Fourth Quarter and Full Year 2022 Results,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Achieves fourth quarter revenue growth of 3%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers fourth quarter EPS of $2.05,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Estimates 2023 EPS of $9.27 - $9.75,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Revenue for the full year,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,"IDEXX Laboratories Inc.: For the full year 2022, EPS of $8.03",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company's revenue guidance,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,100,-0.24,revenues,down,IDEXX Laboratories Inc.: LPD revenue declined 2%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 6%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 27.3% in the quarter,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,100,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Low operating expense growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact ( 0.5%,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -2-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will host a conference call today at 8:30 a.m. (Eastern)",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -2-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,95,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -3-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,95,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -3-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,95,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -3-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,95,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.05 $ 1.89,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -3-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2023 comparable EPS growth,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,99,0.51,products-services,,IDEXX Laboratories Inc.: we have deducted purchases of,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,99,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $828,568 $801,090",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 484,927",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $2.05 $1.89,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -5-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,95,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $2,746,765 $2,437,203",PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -6-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,95,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -6-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -7-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,94,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,PR Newswire,IDEXX Laboratories Announces Fourth Quarter and -7-
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 4Q Net $172.2M,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 4Q Net $172.2M >IDXX
IDXX,2023-02-06,11:30:07,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs 4Q Rev $828.6M >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 4Q Rev $828.6M >IDXX
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Fourth Quarter and Full Year 2022 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Fourth Quarter and Full Year 2022 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Achieves fourth quarter revenue growth of 3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers fourth quarter EPS of $2.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Estimates 2023 EPS of $9.27 - $9.75,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Revenue for the full year,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,"IDEXX Laboratories Inc.: For the full year 2022, EPS of $8.03",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company's revenue guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,-0.24,revenues,down,IDEXX Laboratories Inc.: LPD revenue declined 2%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 6%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 27.3% in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,100,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Low operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact ( 0.5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -2-
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will host a conference call today at 8:30 a.m. (Eastern)",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -2-
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,95,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,95,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,95,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,95,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.05 $ 1.89,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2023 comparable EPS growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $828,568 $801,090",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 484,927",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $2.05 $1.89,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -5-
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,95,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $2,746,765 $2,437,203",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -6-
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,95,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -6-
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -7-
IDXX,2023-02-06,11:30:08,B7EB38,IDEXX Laboratories Inc.,94,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -7-
IDXX,2023-02-06,11:31:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs Sees 2023 Rev $3.59B-$3.69B >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2023 Rev $3.59B-$3.69B >IDXX
IDXX,2023-02-06,11:31:27,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Labs Sees 2023 EPS $9.27,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2023 EPS $9.27-EPS $9.75 >IDXX
IDXX,2023-02-06,11:31:41,B7EB38,IDEXX Laboratories Inc.,100,0.48,revenues,up,Idexx Labs Sees 2023 Organic Revenue Growth 7%-10%,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2023 Organic Revenue Growth 7%-10% >IDXX
IDXX,2023-02-06,11:45:23,B7EB38,IDEXX Laboratories Inc.,100,0.65,revenues,up,Idexx Posts Higher 4Q Revenue,FULL-ARTICLE,Dow Jones Newswires,Idexx Posts Higher 4Q Revenue as Pet-Health Demand Holds up
IDXX,2023-02-06,11:55:05,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Forecasts 2023 Sales Growth,FULL-ARTICLE,Dow Jones Newswires,Idexx Forecasts 2023 Sales Growth on Resilient Pet-Health Demand
IDXX,2023-02-06,11:55:05,B7EB38,IDEXX Laboratories Inc.,100,0.72,revenues,up,IDEXX Laboratories Inc.: The company expects revenue growth,FULL-ARTICLE,Dow Jones Newswires,Idexx Forecasts 2023 Sales Growth on Resilient Pet-Health Demand
IDXX,2023-02-07,09:59:30,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Atlantic Equities,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Atlantic Equities
IDXX,2023-02-07,09:59:30,B7EB38,IDEXX Laboratories Inc.,100,0.8,price-targets,upgrade,Idexx Labs Price Target Raised to $600.00/Share From $470.00 by Atlantic Equities,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $600.00/Share From $470.00 by Atlantic Equities
IDXX,2023-02-07,13:52:51,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by JP Morgan
IDXX,2023-02-07,13:52:51,B7EB38,IDEXX Laboratories Inc.,100,0.54,price-targets,upgrade,Idexx Labs Price Target Raised to $550.00/Share From $525.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $550.00/Share From $525.00 by JP Morgan
IDXX,2023-02-08,13:08:07,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Barclays,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Barclays
IDXX,2023-02-08,13:08:07,B7EB38,IDEXX Laboratories Inc.,100,0.3,price-targets,upgrade,Idexx Labs Price Target Raised to $590.00/Share From $582.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $590.00/Share From $582.00 by Barclays
IDXX,2023-02-10,19:03:43,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Turner Registers 3,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Turner Registers 3,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-02-10,22:01:53,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Hunt Acquires 706 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Hunt Acquires 706 Of IDEXX Laboratories Inc >IDXX
IDXX,2023-02-10,22:12:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,"Dir Szostak Gifts 6,557 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Szostak Gifts 6,557 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-02-13,22:02:36,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Turner Sells 1,000 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Turner Sells 1,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-02-16,23:51:27,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,"Dir Ayers Gifts 21,500 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Gifts 21,500 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-02-16,23:53:00,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Hunt Acquires 552 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Hunt Acquires 552 Of IDEXX Laboratories Inc >IDXX
IDXX,2023-02-16,23:53:35,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Lane Acquires 640 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Lane Acquires 640 Of IDEXX Laboratories Inc >IDXX
IDXX,2023-02-16,23:53:57,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Ceo Mazelsky Acquires 1,904 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mazelsky Acquires 1,904 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-02-16,23:55:03,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Cfo McKeon Acquires 720 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,CFO McKeon Acquires 720 Of IDEXX Laboratories Inc >IDXX
IDXX,2023-02-16,23:55:53,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Polewaczyk Acquires 582 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Polewaczyk Acquires 582 Of IDEXX Laboratories Inc >IDXX
IDXX,2023-02-16,23:56:25,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Smith Acquires 102 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Smith Acquires 102 Of IDEXX Laboratories Inc >IDXX
IDXX,2023-02-16,23:57:31,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Turner Sells 2,000 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Turner Sells 2,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-02-17,22:08:04,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Turner Sells 1,010 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Turner Sells 1,010 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-02-17,22:08:47,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Junius Sells 2,187 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Junius Sells 2,187 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-02-21,21:03:44,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Junius Registers 2,187 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Junius Registers 2,187 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-02-21,21:05:15,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Two Upcoming Institutional Investor Conferences,PRESS-RELEASE,PR Newswire,IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
IDXX,2023-02-21,21:06:40,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Turner Registers 3,736 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Turner Registers 3,736 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-02-21,21:06:53,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Two Upcoming Institutional Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
IDXX,2023-02-21,21:09:51,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Turner Registers 1,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Turner Registers 1,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-02-21,23:04:04,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,"Dir Ayers Gifts 1,000 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Gifts 1,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-03-07,19:36:40,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Turner Registers 3,726 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Turner Registers 3,726 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-03-20,17:27:43,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Turner Registers 3,726 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Turner Registers 3,726 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-03-23,12:19:20,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Morgan Stanley
IDXX,2023-03-23,12:19:20,B7EB38,IDEXX Laboratories Inc.,100,0.72,price-targets,upgrade,Idexx Labs Price Target Raised to $590.00/Share From $543.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $590.00/Share From $543.00 by Morgan Stanley
IDXX,2023-03-23,15:57:25,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Turner Registers 11,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Turner Registers 11,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-04-03,19:21:35,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Turner Registers 1,581 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Turner Registers 1,581 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-04-03,19:21:56,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Turner Registers 7,386 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Turner Registers 7,386 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-04-13,19:00:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2023 First Quarter Financial Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2023 First Quarter Financial Results
IDXX,2023-04-13,19:00:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2023 First Quarter Financial Results
IDXX,2023-04-13,19:01:07,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2023 First Quarter Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2023 First Quarter Financial Results
IDXX,2023-04-13,19:01:07,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2023 First Quarter Financial Results
IDXX,2023-04-23,07:48:27,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 1Q 2023 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories Inc, Inst Holders, 1Q 2023 (IDXX)"
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.32,earnings,,Idexx Laboratories Announces First Quarter Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.63,revenues,up,IDEXX Laboratories Inc.: Achieves first quarter revenue growth of 8%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.55,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.72,revenues,up,"IDEXX Laboratories Inc.: Increases 2023 revenue guidance to $3,615 million - $3,700 million",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.64,earnings,up,IDEXX Laboratories Inc.: Updates 2023 EPS,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company reports revenues of $900 million for the first quarter of 2023,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: First quarter earnings per diluted share,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 10%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,-0.24,revenues,down,IDEXX Laboratories Inc.: LPD revenues declined 5%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 9%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 31.1% in the quarter,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,-0.13,equity-actions,up,IDEXX Laboratories Inc.: Operating expense grew 5%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces First Quarter Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact ( 20 bps,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: The 2023 Annual Meeting,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.55 $ 2.27,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2023 comparable EPS growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,98,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,98,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Annual Report on Form 10-K for the year ended December 31, 2022",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,98,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $900,195 $836,549",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,98,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 542,971",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,98,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,98,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $2.58 $2.30,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,98,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $2.55 $2.27,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,95,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $2,808,398 $2,746,765",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -5-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,95,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -5-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,95,0.59,equity-actions,,IDEXX Laboratories Inc.: Repurchases of common stock,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -5-
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 1Q EPS $2.55,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 1Q EPS $2.55 >IDXX
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 1Q Net $214.1M,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 1Q Net $214.1M >IDXX
IDXX,2023-05-02,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs 1Q Rev $900.2M >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 1Q Rev $900.2M >IDXX
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,100,0.32,earnings,,IDEXX Laboratories Inc.: First quarter results were supported,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,100,0.63,revenues,up,IDEXX Laboratories Inc.: Achieves first quarter revenue growth of 8%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,100,0.72,revenues,up,"IDEXX Laboratories Inc.: Increases 2023 revenue guidance to $3,615 million - $3,700 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,100,0.64,earnings,up,IDEXX Laboratories Inc.: Updates 2023 EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company reports revenues of $900 million for the first quarter of 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: First quarter earnings per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 10%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,100,-0.24,revenues,down,IDEXX Laboratories Inc.: LPD revenues declined 5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 31.1% in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,100,-0.13,equity-actions,up,IDEXX Laboratories Inc.: Operating expense grew 5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact ( 20 bps,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -2-
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -2-
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,IDEXX Laboratories Inc.: The 2023 Annual Meeting,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -2-
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,99,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,99,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.55 $ 2.27,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2023 comparable EPS growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,98,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,98,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Annual Report on Form 10-K for the year ended December 31, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,98,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $900,195 $836,549",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,98,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 542,971",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,98,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,98,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $2.58 $2.30,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,98,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $2.55 $2.27,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,95,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $2,808,398 $2,746,765",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -5-
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,95,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -5-
IDXX,2023-05-02,10:31:20,B7EB38,IDEXX Laboratories Inc.,95,0.59,equity-actions,,IDEXX Laboratories Inc.: Repurchases of common stock,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -5-
IDXX,2023-05-02,10:33:29,B7EB38,IDEXX Laboratories Inc.,100,0.72,revenues,up,Idexx Labs Raises 2023 View To Rev $3.615B-$3.7B,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Raises 2023 View To Rev $3.615B-$3.7B >IDXX
IDXX,2023-05-02,10:33:51,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Labs Sees 2023 EPS $9.33,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2023 EPS $9.33-EPS $9.75 >IDXX
IDXX,2023-05-02,10:51:37,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,Idexx Laboratories said its first-quarter net income rose 10%,FULL-ARTICLE,Dow Jones Newswires,IDEXX 1Q Net Up on Strong Veterinary Software Sales
IDXX,2023-05-02,11:19:07,B7EB38,IDEXX Laboratories Inc.,100,0.72,revenues,up,Idexx hiked its 2023 revenue projection to a range of $3.615 billion to $3.75 billion,FULL-ARTICLE,Dow Jones Newswires,IDEXX Labs Boosts 2023 Revenue Projection Due to Strong Demand
IDXX,2023-05-02,11:19:07,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx now expects 2023 operating margin of 29% to 29.5%,FULL-ARTICLE,Dow Jones Newswires,IDEXX Labs Boosts 2023 Revenue Projection Due to Strong Demand
IDXX,2023-05-04,22:03:30,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Vandebroek Registers 2,187 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Vandebroek Registers 2,187 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-05-05,20:57:41,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Szostak Registers 2,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Szostak Registers 2,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-05-05,21:42:31,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Lane Registers 1,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Lane Registers 1,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-05-05,22:01:50,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Ceo Mazelsky Acquires 560 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,CEO Mazelsky Acquires 560 Of IDEXX Laboratories Inc >IDXX
IDXX,2023-05-05,22:02:52,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Vandebroek Sells 2,187 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Vandebroek Sells 2,187 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-05-08,21:03:10,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,"Dir Ayers Gifts 2,501 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Gifts 2,501 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-05-08,21:03:19,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Lane Sells 1,000 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Lane Sells 1,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-05-08,21:04:23,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Cfo McKeon Acquires 560 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,CFO McKeon Acquires 560 Of IDEXX Laboratories Inc >IDXX
IDXX,2023-05-08,21:04:55,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Szostak Sells 2,000 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Szostak Sells 2,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-05-08,21:05:54,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Underberg Acquires 483 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Underberg Acquires 483 Of IDEXX Laboratories Inc >IDXX
IDXX,2023-05-10,13:15:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Stifel Conference,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Present at Stifel Conference and Announces 2023 Investor Day
IDXX,2023-05-10,13:15:20,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Stifel Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Present at Stifel Conference and Announces 2023 Investor Day
IDXX,2023-05-10,23:24:30,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Turner Registers 4,270 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Turner Registers 4,270 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-05-11,21:07:57,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Dir Ayers Acquires 560 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,Dir Ayers Acquires 560 Of IDEXX Laboratories Inc >IDXX
IDXX,2023-05-16,22:45:56,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Turner Registers 2,510 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Turner Registers 2,510 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-05-17,21:38:46,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,"Dir Ayers Gifts 3,514 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Gifts 3,514 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-05-19,00:00:26,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Ayers Registers 10,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Ayers Registers 10,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-05-19,21:03:25,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Ayers Registers 10,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Ayers Registers 10,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-05-19,21:08:53,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,Ceo Mazelsky Gifts 602 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,CEO Mazelsky Gifts 602 Of IDEXX Laboratories Inc >IDXX
IDXX,2023-05-22,21:02:55,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Ayers Sells 20,000 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Sells 20,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-06-15,10:59:47,B7EB38,IDEXX Laboratories Inc.,100,0.52,products-services,,Idexx Announces Novel Diagnostic Test for,PRESS-RELEASE,PR Newswire,"IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry's Most Comprehensive Renal Testing Portfolio"
IDXX,2023-06-15,10:59:55,B7EB38,IDEXX Laboratories Inc.,100,0.52,products-services,,Idexx Announces Novel Diagnostic Test for,PRESS-RELEASE,Dow Jones Newswires,"Press Release: IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry's Most Comprehensive Renal Testing Portfolio"
IDXX,2023-06-15,11:00:43,B7EB38,IDEXX Laboratories Inc.,100,0.52,products-services,,Idexx Announces Novel Diagnostic Test for,NEWS-FLASH,Dow Jones Newswires,IDEXX Announces Novel Diagnostic Test for Kidney Injury
IDXX,2023-06-15,11:03:07,B7EB38,IDEXX Laboratories Inc.,100,0.52,products-services,,Idexx Labs Launches First Veterinary Diagnostic Test for,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Launches First Veterinary Diagnostic Test for Detecting Kidney Injury in Cats and Dogs >IDXX
IDXX,2023-06-29,19:00:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2023 Second Quarter Financial Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2023 Second Quarter Financial Results
IDXX,2023-06-29,19:00:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2023 Second Quarter Financial Results
IDXX,2023-06-29,19:10:18,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2023 Second Quarter Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2023 Second Quarter Financial Results
IDXX,2023-06-29,19:10:18,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2023 Second Quarter Financial Results
IDXX,2023-07-12,11:00:00,B7EB38,IDEXX Laboratories Inc.,100,0.47,labor-issues,,Idexx Laboratories Elects Irene Chang Britt to Board of Directors,PRESS-RELEASE,Business Wire,IDEXX Laboratories Elects Irene Chang Britt to Board of Directors
IDXX,2023-07-12,11:00:22,B7EB38,IDEXX Laboratories Inc.,100,0.47,labor-issues,,Idexx Laboratories Elects Irene Chang Britt to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,IDEXX Laboratories Elects Irene Chang Britt to Bd of Directors
IDXX,2023-07-12,11:00:40,B7EB38,IDEXX Laboratories Inc.,100,0.47,labor-issues,,Idexx Laboratories Elects Irene Chang Britt to Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Elects Irene Chang Britt to Board of Directors
IDXX,2023-08-01,10:30:00,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 2Q EPS $2.67,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 2Q EPS $2.67 >IDXX
IDXX,2023-08-01,10:30:00,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 2Q Net $224.2M,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 2Q Net $224.2M >IDXX
IDXX,2023-08-01,10:30:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs 2Q Rev $943.6M >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 2Q Rev $943.6M >IDXX
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Second Quarter Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Records second quarter revenue growth of 10%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.67,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Updates 2023 revenue,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Increases 2023 EPS,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Second quarter earnings per diluted share,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 11%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,unchanged,IDEXX Laboratories Inc.: LPD revenues were flat on a reported basis,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 11%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 31.4% in the quarter,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.62,revenues,up,IDEXX Laboratories Inc.: Operating margin expansion,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.48,equity-actions,down,IDEXX Laboratories Inc.: Reported operating expense declines,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.7,earnings,above-expectations,IDEXX Laboratories Inc.: The Company's higher EPS outlook,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact 20 bps,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -2-
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -2-
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.67 $ 1.56,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2023 comparable EPS growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Annual Report on Form 10-K for the year ended December 31, 2022",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $943,630 $860,546",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 572,850",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $2.70 $1.57,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $2.67 $1.56,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,94,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $2,870,806 $2,746,765",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -5-
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,95,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -6-
IDXX,2023-08-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,95,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -6-
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Second Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Records second quarter revenue growth of 10%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.67,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Updates 2023 revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Increases 2023 EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Second quarter earnings per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 11%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,unchanged,IDEXX Laboratories Inc.: LPD revenues were flat on a reported basis,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 11%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 31.4% in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,100,0.62,revenues,up,IDEXX Laboratories Inc.: Operating margin expansion,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,100,0.48,equity-actions,down,IDEXX Laboratories Inc.: Reported operating expense declines,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,100,0.7,earnings,above-expectations,IDEXX Laboratories Inc.: The Company's higher EPS outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact 20 bps,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -2-
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -2-
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,97,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.67 $ 1.56,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,97,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2023 comparable EPS growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,97,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Annual Report on Form 10-K for the year ended December 31, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,97,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $943,630 $860,546",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 572,850",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $2.70 $1.57,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $2.67 $1.56,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,94,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $2,870,806 $2,746,765",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -5-
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,94,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -6-
IDXX,2023-08-01,10:31:00,B7EB38,IDEXX Laboratories Inc.,94,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -6-
IDXX,2023-08-01,10:35:25,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs Sees 2023 Rev $3.66B-$3.715B >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2023 Rev $3.66B-$3.715B >IDXX
IDXX,2023-08-01,10:35:47,B7EB38,IDEXX Laboratories Inc.,100,0.7,earnings,up,Idexx Labs Raises 2023 View To EPS $9.64,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Raises 2023 View To EPS $9.64-EPS $9.90 >IDXX
IDXX,2023-08-02,17:30:28,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by JP Morgan
IDXX,2023-08-02,17:30:28,B7EB38,IDEXX Laboratories Inc.,100,0.74,price-targets,upgrade,Idexx Labs Price Target Raised to $600.00/Share From $550.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $600.00/Share From $550.00 by JP Morgan
IDXX,2023-08-03,14:59:21,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Morgan Stanley
IDXX,2023-08-03,14:59:21,B7EB38,IDEXX Laboratories Inc.,100,0.32,price-targets,upgrade,Idexx Labs Price Target Raised to $600.00/Share From $590.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $600.00/Share From $590.00 by Morgan Stanley
IDXX,2023-08-03,22:03:27,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Lane Registers 16,027 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Lane Registers 16,027 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-08-07,21:08:05,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Lane Sells 16,027 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Lane Sells 16,027 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-08-08,22:00:25,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Ceo Mazelsky Acquires 214 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,CEO Mazelsky Acquires 214 Of IDEXX Laboratories Inc >IDXX
IDXX,2023-08-08,22:01:04,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Cfo McKeon Acquires 75 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,CFO McKeon Acquires 75 Of IDEXX Laboratories Inc >IDXX
IDXX,2023-08-14,21:04:51,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,"Dir Ayers Gifts 1,000 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Gifts 1,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-08-17,23:39:07,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,Dir Ayers Sells 492 Of IDEXX Laboratories Inc,TABULAR-MATERIAL,Dow Jones Newswires,Dir Ayers Sells 492 Of IDEXX Laboratories Inc >IDXX
IDXX,2023-08-19,07:36:22,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 2Q 2023 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories Inc, Inst Holders, 2Q 2023 (IDXX)"
IDXX,2023-08-29,21:27:39,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Polewaczyk Registers 22,909 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Polewaczyk Registers 22,909 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-08-31,21:18:35,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Polewaczyk Sells 22,909 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Polewaczyk Sells 22,909 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-08-31,22:06:31,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Ceo Mazelsky Registers 13,424 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"CEO Mazelsky Registers 13,424 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-09-05,21:02:17,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Ceo Mazelsky Sells 13,424 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mazelsky Sells 13,424 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-09-05,21:02:31,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,"Dir Ayers Gifts 1,500 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Gifts 1,500 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-09-06,21:04:26,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Smith Acquires 14 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Smith Acquires 14 Of IDEXX Laboratories Inc >IDXX
IDXX,2023-09-15,13:02:36,B7EB38,IDEXX Laboratories Inc.,100,0.0,analyst-ratings,neutral,Idexx Labs Is Maintained at Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Hold by Stifel
IDXX,2023-09-15,13:02:36,B7EB38,IDEXX Laboratories Inc.,100,-0.56,price-targets,downgrade,Idexx Labs Price Target Cut to $500.00/Share From $525.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $500.00/Share From $525.00 by Stifel
IDXX,2023-10-05,20:27:23,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2023 Third Quarter Financial Results
IDXX,2023-10-05,20:00:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2023 Third Quarter Financial Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2023 Third Quarter Financial Results
IDXX,2023-10-05,20:00:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2023 Third Quarter Financial Results
IDXX,2023-10-05,20:27:23,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2023 Third Quarter Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2023 Third Quarter Financial Results
IDXX,2023-10-30,15:20:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,analyst-ratings,neutral,Idexx Labs Is Maintained at Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Hold by Stifel
IDXX,2023-10-30,15:20:03,B7EB38,IDEXX Laboratories Inc.,100,-0.72,price-targets,downgrade,Idexx Labs Price Target Cut to $460.00/Share From $500.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $460.00/Share From $500.00 by Stifel
IDXX,2023-11-01,10:30:00,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 3Q EPS $2.53,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 3Q EPS $2.53 >IDXX
IDXX,2023-11-01,10:30:00,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 3Q Net $212.2M,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 3Q Net $212.2M >IDXX
IDXX,2023-11-01,10:30:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs 3Q Rev $915.5M >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 3Q Rev $915.5M >IDXX
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Third Quarter Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.63,revenues,up,IDEXX Laboratories Inc.: Achieves third quarter revenue growth of 9%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.53,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Adjusts 2023 revenue,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.64,earnings,up,IDEXX Laboratories Inc.: Updates 2023 EPS,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Third quarter earnings per diluted share,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 9%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 8%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 30.1% in the quarter,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.62,revenues,up,IDEXX Laboratories Inc.: Operating margin expansion,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Reported operating expense growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Third Quarter Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results -2-
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact ( 40 bps,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results -2-
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter Results -2-
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.65,revenues,up,IDEXX Laboratories Inc.: 2023 revenue growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.53 $ 2.15,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2023-11-01,10:33:28,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Labs Adjusts 2023 View,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Adjusts 2023 View To EPS $9.74-EPS $9.90 >IDXX
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2023 comparable EPS growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -3-
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Annual Report on Form 10-K for the year ended December 31, 2022",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $915,527 $841,661",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 547,982",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $ 2.55 $ 2.17 $,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $ 2.53 $ 2.15 $,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -4-
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,94,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $ 3,086,404 $ 2,746,765",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -5-
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,95,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -6-
IDXX,2023-11-01,10:30:01,B7EB38,IDEXX Laboratories Inc.,95,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Third Quarter -6-
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Third Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.63,revenues,up,IDEXX Laboratories Inc.: Achieves third quarter revenue growth of 9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Adjusts 2023 revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.64,earnings,up,IDEXX Laboratories Inc.: Updates 2023 EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Third quarter earnings per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Rapid assay products revenues grew 9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 8%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 30.1% in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,100,0.62,revenues,up,IDEXX Laboratories Inc.: Operating margin expansion,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,100,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Reported operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third Quarter Results
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact ( 40 bps,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -2-
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -2-
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,97,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.53 $ 2.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,97,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2023 comparable EPS growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,97,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -3-
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Annual Report on Form 10-K for the year ended December 31, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,97,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $915,527 $841,661",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 547,982",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,97,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $ 2.55 $ 2.17 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,97,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $ 2.53 $ 2.15 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -4-
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,94,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $ 3,086,404 $ 2,746,765",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -5-
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,94,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -6-
IDXX,2023-11-01,10:30:20,B7EB38,IDEXX Laboratories Inc.,94,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Third -6-
IDXX,2023-11-01,10:33:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Labs Adjusts 2023 View,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Adjusts 2023 View To Rev $3.635B-$3.650B >IDXX
IDXX,2023-11-01,10:58:20,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,Idexx Laboratories posted 17% growth in third-quarter net income,FULL-ARTICLE,Dow Jones Newswires,Idexx 3Q Net Income Rises Sharply on Rising Demand for Vet Tech Products
IDXX,2023-11-01,10:58:44,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,Idexx Laboratories posted 17% growth in third-quarter net income,FULL-ARTICLE,Dow Jones Newswires,Idexx 3Q Net Up Sharply on Rising Demand for Vet Tech Products
IDXX,2023-11-01,11:01:42,B7EB38,IDEXX Laboratories Inc.,100,0.7,earnings,up,Idexx Boosts Lower End of 2023 Earnings Projection,FULL-ARTICLE,Dow Jones Newswires,"Idexx Boosts Lower End of 2023 Earnings Projection, Cuts Revenue View"
IDXX,2023-11-02,15:31:34,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Barclays,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Barclays
IDXX,2023-11-02,15:31:34,B7EB38,IDEXX Laboratories Inc.,100,0.3,price-targets,upgrade,Idexx Labs Price Target Raised to $592.00/Share From $590.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $592.00/Share From $590.00 by Barclays
IDXX,2023-11-02,21:54:35,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by JP Morgan
IDXX,2023-11-02,21:54:35,B7EB38,IDEXX Laboratories Inc.,100,-0.74,price-targets,downgrade,Idexx Labs Price Target Cut to $550.00/Share From $600.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $550.00/Share From $600.00 by JP Morgan
IDXX,2023-11-03,14:52:27,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Buy by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Buy by Goldman Sachs
IDXX,2023-11-03,14:52:27,B7EB38,IDEXX Laboratories Inc.,100,-0.8,price-targets,downgrade,Idexx Labs Price Target Cut to $500.00/Share From $578.00 by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $500.00/Share From $578.00 by Goldman Sachs
IDXX,2023-11-06,15:30:19,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Piper Sandler,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Piper Sandler
IDXX,2023-11-06,15:30:19,B7EB38,IDEXX Laboratories Inc.,100,0.3,price-targets,upgrade,Idexx Labs Price Target Raised to $525.00/Share From $520.00 by Piper Sandler,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $525.00/Share From $520.00 by Piper Sandler
IDXX,2023-11-08,12:00:05,B7EB38,IDEXX Laboratories Inc.,100,0.44,products-services,,Idexx Expands SNAP Platform with,PRESS-RELEASE,PR Newswire,IDEXX Expands SNAP Platform with Leish 4Dx Test to Support Veterinarians Globally in Diagnosing Vector-borne Diseases
IDXX,2023-11-08,12:00:53,B7EB38,IDEXX Laboratories Inc.,100,0.44,products-services,,Idexx Expands SNAP Platform with,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Expands SNAP Platform with Leish 4Dx Test to Support Veterinarians Globally in Diagnosing Vector-borne Diseases
IDXX,2023-11-08,12:00:53,B7EB38,IDEXX Laboratories Inc.,100,0.44,products-services,,Idexx Expands SNAP Platform with,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Expands SNAP Platform with Leish 4Dx Test to Support Veterinarians Globally in Diagnosing Vector-borne Diseases
IDXX,2023-11-16,23:51:59,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,"Dir Ayers Gifts 2,494 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Gifts 2,494 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-11-19,08:37:34,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 3Q 2023 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories  Inc, Inst Holders, 3Q 2023 (IDXX)"
IDXX,2023-11-22,22:01:47,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,"Dir Ayers Gifts 2,506 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Gifts 2,506 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-12-01,22:02:30,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,"Dir Ayers Gifts 1,850 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Gifts 1,850 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-12-04,22:07:02,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Ceo Mazelsky Registers 7,128 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"CEO Mazelsky Registers 7,128 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-12-06,22:01:33,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,"Dir Ayers Gifts 2,424 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Ayers Gifts 2,424 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-12-06,22:02:51,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Ceo Mazelsky Sells 7,128 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mazelsky Sells 7,128 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-12-07,21:25:53,B7EB38,IDEXX Laboratories Inc.,100,-0.49,labor-issues,,"Polewaczyk, Chief Commercial Officer of IDEXX Laboratories, to Retire",RNS-SEC8K,Dow Jones Newswires,"James F. Polewaczyk, Chief Commercial Officer of IDEXX Laboratories, to Retire April 1"
IDXX,2023-12-07,22:06:39,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Polewaczyk Registers 11,636 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Polewaczyk Registers 11,636 Of IDEXX Laboratories Inc >IDXX"
IDXX,2023-12-08,22:06:04,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Polewaczyk Sells 11,636 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Polewaczyk Sells 11,636 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-01-16,21:15:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results
IDXX,2025-01-16,21:15:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results
IDXX,2025-01-16,21:15:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results
IDXX,2025-01-16,22:47:38,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results
IDXX,2025-01-16,22:47:38,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results
IDXX,2025-01-16,22:47:38,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results
IDXX,2025-01-29,17:50:44,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Morgan Stanley
IDXX,2025-01-29,17:50:44,B7EB38,IDEXX Laboratories Inc.,100,-0.32,price-targets,downgrade,Idexx Labs Price Target Cut to $550.00/Share From $559.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $550.00/Share From $559.00 by Morgan Stanley
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,4Q EPS $2.62 >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 4Q EPS $2.62 >IDXX
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 4Q Net $216.1M,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 4Q Net $216.1M >IDXX
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs 4Q Rev $954.3M >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 4Q Rev $954.3M >IDXX
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Fourth Quarter and Full Year 2024 Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Fourth Quarter and Full Year 2024 Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,"IDEXX Laboratories Inc.: The Company reports revenues of $954 million for the fourth quarter of 2024, an increase of 6% compared to the prior year",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers fourth quarter EPS of $2.62,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Estimates 2025 EPS of $11.74 - $12.24,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.59,equity-actions,,IDEXX Laboratories Inc.: Outlook assumes $1.5 billion of share repurchases,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Revenue for the full year,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,"IDEXX Laboratories Inc.: For the full year 2024, EPS of $10.67",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: The Company's initial 2025 revenue guidance,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 8%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 27.4% in the quarter,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,-0.16,equity-actions,up,IDEXX Laboratories Inc.: Operating expenses grew 10%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: 2025 Growth and Financial Performance,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact ( 2%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and -2-
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will host a conference call today at 8:30 a.m. (Eastern)",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and -2-
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,93,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and -3-
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,93,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and -3-
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,93,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.62 $ 2.32,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and -3-
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,93,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2025 comparable EPS growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and -3-
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2024",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $954,288 $901,601",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 570,660",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $ 2.64 $ 2.34 $,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $ 2.62 $ 2.32 $,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and -4-
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,93,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and -5-
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,94,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $ 3,293,443 $ 3,259,925",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and -6-
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,94,0.0,revenues,,IDEXX Laboratories Inc.: Selected Days sales,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and -6-
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and -7-
IDXX,2025-02-03,11:30:01,B7EB38,IDEXX Laboratories Inc.,94,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Fourth Quarter and -7-
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Fourth Quarter and Full Year 2024 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Fourth Quarter and Full Year 2024 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,"IDEXX Laboratories Inc.: The Company reports revenues of $954 million for the fourth quarter of 2024, an increase of 6% compared to the prior year",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers fourth quarter EPS of $2.62,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Estimates 2025 EPS of $11.74 - $12.24,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.59,equity-actions,,IDEXX Laboratories Inc.: Outlook assumes $1.5 billion of share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Revenue for the full year,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,"IDEXX Laboratories Inc.: For the full year 2024, EPS of $10.67",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: The Company's initial 2025 revenue guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 8%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 27.4% in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,100,-0.16,equity-actions,up,IDEXX Laboratories Inc.: Operating expenses grew 10%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: 2025 Growth and Financial Performance,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact ( 2%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -2-
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will host a conference call today at 8:30 a.m. (Eastern)",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -2-
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,93,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,93,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,93,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.62 $ 2.32,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,93,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2025 comparable EPS growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -3-
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $954,288 $901,601",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 570,660",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $ 2.64 $ 2.34 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $ 2.62 $ 2.32 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,93,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -5-
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,94,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $ 3,293,443 $ 3,259,925",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -6-
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,94,0.0,revenues,,IDEXX Laboratories Inc.: Selected Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -6-
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -7-
IDXX,2025-02-03,11:30:02,B7EB38,IDEXX Laboratories Inc.,94,0.59,equity-actions,,IDEXX Laboratories Inc.: Shares repurchased,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -7-
IDXX,2025-02-03,11:30:38,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs Sees 2025 Rev $4.055B-$4.17B >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2025 Rev $4.055B-$4.17B >IDXX
IDXX,2025-02-03,11:30:54,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Labs Sees 2025 EPS $11.74,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2025 EPS $11.74-EPS $12.24 >IDXX
IDXX,2025-02-03,11:31:14,B7EB38,IDEXX Laboratories Inc.,100,0.48,revenues,up,Idexx Labs Sees 2025 Organic Revenue Growth 6%-9%,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2025 Organic Revenue Growth 6%-9% >IDXX
IDXX,2025-02-03,11:31:18,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,"IDEXX Laboratories Inc.: the ""Company"") announced its financial results for the quarter and year ended December 31, 2024",RNS-SEC8K,Dow Jones Newswires,IDEXX Labs Files 8K - Operations And Financial Condition >IDXX
IDXX,2025-02-03,11:33:39,B7EB38,IDEXX Laboratories Inc.,100,0.0,equity-actions,,Idexx Labs Sees 2025 Capital Spending About $160 Million >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2025 Capital Spending About $160 Million >IDXX
IDXX,2025-02-03,11:54:47,B7EB38,IDEXX Laboratories Inc.,100,0.72,revenues,above-expectations,Idexx Labs 4Q Revenue Tops Estimates,FULL-ARTICLE,Dow Jones Newswires,Idexx Labs 4Q Revenue Tops Estimates; 2025 Outlook Issued
IDXX,2025-02-03,11:54:47,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx forecast revenue between $4.06 billion,FULL-ARTICLE,Dow Jones Newswires,Idexx Labs 4Q Revenue Tops Estimates; 2025 Outlook Issued
IDXX,2025-02-03,15:04:07,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,above-expectations,Idexx Laboratories handily beat Wall Street's fourth-quarter expectations,FULL-ARTICLE,Dow Jones Newswires,"Idexx Laboratories Barks Up A Beat, And Shares Jump To A Four-Month High -- IBD"
IDXX,2025-02-03,15:04:07,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: the company earned $2.62 per share,FULL-ARTICLE,Dow Jones Newswires,"Idexx Laboratories Barks Up A Beat, And Shares Jump To A Four-Month High -- IBD"
IDXX,2025-02-03,21:03:07,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,above-expectations,Idexx Laboratories handily beat Wall Street's fourth-quarter expectations,FULL-ARTICLE,Dow Jones Newswires,"Idexx Laboratories Barks Up A Beat, And Shares Jump To A Four-Month High -- IBD"
IDXX,2025-02-03,21:03:07,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: the company earned $2.62 per share,FULL-ARTICLE,Dow Jones Newswires,"Idexx Laboratories Barks Up A Beat, And Shares Jump To A Four-Month High -- IBD"
IDXX,2025-02-04,11:51:57,B7EB38,IDEXX Laboratories Inc.,100,0.0,analyst-ratings,neutral,Idexx Labs Is Maintained at Neutral by B of A Securities,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Neutral by B of A Securities
IDXX,2025-02-04,11:51:57,B7EB38,IDEXX Laboratories Inc.,100,0.78,price-targets,upgrade,Idexx Labs Price Target Raised to $535.00/Share From $475.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $535.00/Share From $475.00 by B of A Securities
IDXX,2025-02-04,13:14:27,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Barclays,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Barclays
IDXX,2025-02-04,13:14:27,B7EB38,IDEXX Laboratories Inc.,100,0.7,price-targets,upgrade,Idexx Labs Price Target Raised to $520.00/Share From $481.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $520.00/Share From $481.00 by Barclays
IDXX,2025-02-07,21:09:43,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Szostak Registers 3,000 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Szostak Registers 3,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-02-10,15:06:51,B7EB38,IDEXX Laboratories Inc.,100,0.0,analyst-ratings,neutral,Idexx Labs Is Maintained at Neutral by Piper Sandler,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Neutral by Piper Sandler
IDXX,2025-02-10,15:06:51,B7EB38,IDEXX Laboratories Inc.,100,0.78,price-targets,upgrade,Idexx Labs Price Target Raised to $510.00/Share From $435.00 by Piper Sandler,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $510.00/Share From $435.00 by Piper Sandler
IDXX,2025-02-10,22:04:04,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Szostak Sells 3,000 Of IDEXX Laboratories Inc",FULL-ARTICLE,Dow Jones Newswires,"Dir Szostak Sells 3,000 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-02-10,22:54:35,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Fennell Registers 9,966 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Fennell Registers 9,966 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-02-11,22:00:53,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Fennell Sells 9,986 Of IDEXX Laboratories Inc",FULL-ARTICLE,Dow Jones Newswires,"VP Fennell Sells 9,986 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-02-12,22:10:01,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Vp Erickson Acquires 1,544 Of IDEXX Laboratories Inc >IDXX",FULL-ARTICLE,Dow Jones Newswires,"VP Erickson Acquires 1,544 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-02-13,19:00:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Two Upcoming Institutional Investor Conferences,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
IDXX,2025-02-14,21:01:12,B7EB38,IDEXX Laboratories Inc.,97,-0.51,labor-issues,,"On February 13, 2025, Dr. Asha Collins resigned from the Board of Directors (the ""Board"") of IDEXX Laboratories, Inc.",RNS-SEC8K,Dow Jones Newswires,"IDEXX Labs Files 8K - Director, Officer or Compensation Filing >IDXX"
IDXX,2025-02-14,21:03:52,B7EB38,IDEXX Laboratories Inc.,100,-0.51,labor-issues,,"Idexx Laboratories, Inc.: Asha Collins Resigned From the Board",NEWS-FLASH,Dow Jones Newswires,"IDEXX Laboratories, Inc.: Asha Collins Resigned From the Board >IDXX"
IDXX,2025-02-19,02:44:25,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Erickson Acquires 380 Of IDEXX Laboratories Inc >IDXX,FULL-ARTICLE,Dow Jones Newswires,VP Erickson Acquires 380 Of IDEXX Laboratories Inc >IDXX
IDXX,2025-02-19,02:44:45,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Fennell Acquires 171 Of IDEXX Laboratories Inc >IDXX,FULL-ARTICLE,Dow Jones Newswires,VP Fennell Acquires 171 Of IDEXX Laboratories Inc >IDXX
IDXX,2025-02-19,02:45:29,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,Vp Underberg Surrenders 219 Of IDEXX Laboratories Inc >IDXX,FULL-ARTICLE,Dow Jones Newswires,VP Underberg Surrenders 219 Of IDEXX Laboratories Inc >IDXX
IDXX,2025-02-19,02:45:57,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Hunt Acquires 604 Of IDEXX Laboratories Inc >IDXX,FULL-ARTICLE,Dow Jones Newswires,VP Hunt Acquires 604 Of IDEXX Laboratories Inc >IDXX
IDXX,2025-02-19,02:46:19,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Johnson Acquires 237 Of IDEXX Laboratories Inc >IDXX,FULL-ARTICLE,Dow Jones Newswires,VP Johnson Acquires 237 Of IDEXX Laboratories Inc >IDXX
IDXX,2025-02-19,02:46:43,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Lane Acquires 613 Of IDEXX Laboratories Inc >IDXX,FULL-ARTICLE,Dow Jones Newswires,VP Lane Acquires 613 Of IDEXX Laboratories Inc >IDXX
IDXX,2025-02-19,02:47:03,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Ceo Mazelsky Acquires 1,525 Of IDEXX Laboratories Inc >IDXX",FULL-ARTICLE,Dow Jones Newswires,"CEO Mazelsky Acquires 1,525 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-02-19,02:47:25,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Vp Schreck Acquires 1,018 Of IDEXX Laboratories Inc >IDXX",FULL-ARTICLE,Dow Jones Newswires,"VP Schreck Acquires 1,018 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-02-19,02:50:20,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Smith Acquires 857 Of IDEXX Laboratories Inc >IDXX,FULL-ARTICLE,Dow Jones Newswires,VP Smith Acquires 857 Of IDEXX Laboratories Inc >IDXX
IDXX,2025-02-19,02:50:50,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Cfo McKeon Acquires 593 Of IDEXX Laboratories Inc >IDXX,FULL-ARTICLE,Dow Jones Newswires,CFO McKeon Acquires 593 Of IDEXX Laboratories Inc >IDXX
IDXX,2025-02-19,08:01:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 4Q 2024 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories  Inc, Inst Holders, 4Q 2024 (IDXX)"
IDXX,2025-02-20,08:01:09,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 4Q 2024 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories  Inc, Inst Holders, 4Q 2024 (IDXX)"
IDXX,2025-04-03,17:30:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2025 First Quarter Financial Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2025 First Quarter Financial Results
IDXX,2025-04-03,17:30:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2025 First Quarter Financial Results
IDXX,2025-04-03,17:31:16,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2025 First Quarter Financial Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2025 First Quarter Financial Results
IDXX,2025-04-03,17:31:16,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Release 2025 First Quarter Financial Results
IDXX,2025-04-14,14:26:14,B7EB38,IDEXX Laboratories Inc.,100,0.0,analyst-ratings,neutral,Idexx Labs Is Maintained at Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Hold by Stifel
IDXX,2025-04-14,14:26:14,B7EB38,IDEXX Laboratories Inc.,100,-0.66,price-targets,downgrade,Idexx Labs Price Target Cut to $420.00/Share From $450.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Cut to $420.00/Share From $450.00 by Stifel
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces First Quarter Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Achieves first quarter revenue growth of 4%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.96,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Adjusts 2025 revenue,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Updates guidance for 2025,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.64,earnings,up,IDEXX Laboratories Inc.: Updates 2025 EPS,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: First quarter earnings per diluted share,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,-0.68,revenues,down,IDEXX Laboratories Inc.: Rapid assay products revenues declined,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Water revenues grew 5%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 5%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 31.7% for the quarter,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company updated its full year reported operating margin outlook,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces First Quarter Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact (1%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: The 2025 Annual Meeting,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter Results -2-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,1Q EPS $2.96 >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 1Q EPS $2.96 >IDXX
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,96,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,96,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,96,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,96,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.96 $ 2.81,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,96,0.64,earnings,up,IDEXX Laboratories Inc.: Comparable EPS growth $ 2.91 $ 2.71,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,96,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2025 comparable EPS growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -3-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Segment Income from Operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Annual Report on Form 10-K for the year ended December 31, 2024",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $998,427 $964,095",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 623,379",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $ 2.98 $ 2.84,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $ 2.96 $ 2.81,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 1Q Net $242.7M,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 1Q Net $242.7M >IDXX
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs 1Q Rev $998.4M >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 1Q Rev $998.4M >IDXX
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -5-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,94,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $3,213,689 $ 3,293,443",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -5-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,94,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -5-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,94,0.59,equity-actions,,IDEXX Laboratories Inc.: Repurchases of common stock,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces First Quarter -6-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: First Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Achieves first quarter revenue growth of 4%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $2.96,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Adjusts 2025 revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Updates guidance for 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.64,earnings,up,IDEXX Laboratories Inc.: Updates 2025 EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: First quarter earnings per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,-0.68,revenues,down,IDEXX Laboratories Inc.: Rapid assay products revenues declined,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Water revenues grew 5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 31.7% for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company updated its full year reported operating margin outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First Quarter Results
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact (1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -2-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -2-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,IDEXX Laboratories Inc.: The 2025 Annual Meeting,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -2-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,96,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,96,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,96,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,96,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $ 2.96 $ 2.81,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,96,0.64,earnings,up,IDEXX Laboratories Inc.: Comparable EPS growth $ 2.91 $ 2.71,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,96,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2025 comparable EPS growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -3-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Segment Income from Operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Annual Report on Form 10-K for the year ended December 31, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $998,427 $964,095",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 623,379",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $ 2.98 $ 2.84,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,99,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $ 2.96 $ 2.81,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -4-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,IDEXX Laboratories Inc.: Income from Operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -5-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,94,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $3,213,689 $ 3,293,443",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -5-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,94,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -5-
IDXX,2025-05-01,10:30:03,B7EB38,IDEXX Laboratories Inc.,94,0.59,equity-actions,,IDEXX Laboratories Inc.: Repurchases of common stock,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces First -6-
IDXX,2025-05-01,10:30:46,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs Sees 2025 Rev $4.095B-$4.21B >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2025 Rev $4.095B-$4.21B >IDXX
IDXX,2025-05-01,10:30:54,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,"IDEXX Laboratories Inc.: the ""Company"") announced its financial results for the quarter ended March 31, 2025",RNS-SEC8K,Dow Jones Newswires,IDEXX Labs Files 8K - Operations And Financial Condition >IDXX
IDXX,2025-05-01,10:31:12,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Labs Sees 2025 EPS $11.93,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Sees 2025 EPS $11.93-EPS $12.43 >IDXX
IDXX,2025-05-02,20:24:37,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Collins Registers 2,671 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Collins Registers 2,671 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-05-05,14:39:38,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Morgan Stanley
IDXX,2025-05-05,14:39:38,B7EB38,IDEXX Laboratories Inc.,100,0.34,price-targets,upgrade,Idexx Labs Price Target Raised to $558.00/Share From $548.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $558.00/Share From $548.00 by Morgan Stanley
IDXX,2025-05-09,20:22:25,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Vandebroek Registers 1,279 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Vandebroek Registers 1,279 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-05-13,18:30:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Stifel Conference,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day
IDXX,2025-05-13,18:30:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Present at Stifel Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day
IDXX,2025-05-13,21:01:05,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Vandebroek Sells 1,279 Of IDEXX Laboratories Inc",FULL-ARTICLE,Dow Jones Newswires,"Dir Vandebroek Sells 1,279 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-05-13,23:33:26,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Junius Registers 2,683 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Junius Registers 2,683 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-05-14,21:01:25,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Junius Sells 2,683 Of IDEXX Laboratories Inc",FULL-ARTICLE,Dow Jones Newswires,"Dir Junius Sells 2,683 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-05-19,07:01:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 1Q 2025 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories  Inc, Inst Holders, 1Q 2025 (IDXX)"
IDXX,2025-05-19,14:15:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,analyst-ratings,neutral,Idexx Labs Is Maintained at Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Hold by Stifel
IDXX,2025-05-19,14:15:00,B7EB38,IDEXX Laboratories Inc.,100,0.78,price-targets,upgrade,Idexx Labs Price Target Raised to $510.00/Share From $460.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $510.00/Share From $460.00 by Stifel
IDXX,2025-05-21,20:03:34,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Szostak Registers 1,260 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Szostak Registers 1,260 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-05-21,20:03:45,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Szostak Registers 1,046 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Szostak Registers 1,046 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-05-23,21:01:32,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Szostak Sells 2,306 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Szostak Sells 2,306 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-06-03,21:05:45,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Vp Johnson Acquires 1,883 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"VP Johnson Acquires 1,883 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-06-11,18:23:46,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Outperform by Leerink,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Outperform by Leerink Partners
IDXX,2025-06-11,18:23:46,B7EB38,IDEXX Laboratories Inc.,100,0.78,price-targets,upgrade,Idexx Labs Price Target Raised to $580.00/Share From $515.00 by Leerink,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $580.00/Share From $515.00 by Leerink Partners
IDXX,2025-06-24,17:00:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2025 Second Quarter Financial Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2025 Second Quarter Financial Results
IDXX,2025-06-24,17:00:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2025 Second Quarter Financial Results
IDXX,2025-07-02,17:35:14,B7EB38,IDEXX Laboratories Inc.,100,0.0,analyst-ratings,neutral,Idexx Labs Is Maintained at Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Hold by Stifel
IDXX,2025-07-02,17:35:14,B7EB38,IDEXX Laboratories Inc.,100,0.62,price-targets,upgrade,Idexx Labs Price Target Raised to $540.00/Share From $510.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $540.00/Share From $510.00 by Stifel
IDXX,2025-07-10,11:00:00,B7EB38,IDEXX Laboratories Inc.,100,0.47,labor-issues,,Idexx Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors,PRESS-RELEASE,Business Wire,IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors
IDXX,2025-07-10,11:00:01,B7EB38,IDEXX Laboratories Inc.,100,0.47,labor-issues,,Idexx Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors
IDXX,2025-07-10,11:00:23,B7EB38,IDEXX Laboratories Inc.,100,0.47,labor-issues,,Idexx Laboratories Names Joseph Hooley to Board,NEWS-FLASH,Dow Jones Newswires,IDEXX Laboratories Names Joseph Hooley to Board >IDXX
IDXX,2025-07-10,11:01:08,B7EB38,IDEXX Laboratories Inc.,99,0.53,labor-issues,,"IDEXX Laboratories Inc.: the ""Company"") elected Joseph L. (Jay) Hooley as an independent Class III Director",RNS-SEC8K,Dow Jones Newswires,"IDEXX Labs Files 8K - Director, Officer or Compensation Filing >IDXX"
IDXX,2025-07-17,19:48:09,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Outperform by Leerink,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Outperform by Leerink Partners
IDXX,2025-07-17,19:48:09,B7EB38,IDEXX Laboratories Inc.,100,0.48,price-targets,upgrade,Idexx Labs Price Target Raised to $600.00/Share From $580.00 by Leerink,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $600.00/Share From $580.00 by Leerink Partners
IDXX,2025-07-30,11:00:09,B7EB38,IDEXX Laboratories Inc.,99,0.39,products-services,,IDEXX Laboratories Inc.: Signed three virtual power purchase agreements,PRESS-RELEASE,PR Newswire,"IDEXX Releases 2024 Corporate Responsibility Report, Highlighting Progress Against Its Goals"
IDXX,2025-07-30,11:12:26,B7EB38,IDEXX Laboratories Inc.,99,0.39,products-services,,IDEXX Laboratories Inc.: Signed three virtual power purchase agreements,PRESS-RELEASE,Dow Jones Newswires,"Press Release: IDEXX Releases 2024 Corporate Responsibility Report, Highlighting Progress Against Its Goals"
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,2Q EPS $3.63 >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 2Q EPS $3.63 >IDXX
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,Idexx Labs 2Q Net $294M,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 2Q Net $294M >IDXX
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,Idexx Labs 2Q Rev $1.11B >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs 2Q Rev $1.11B >IDXX
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories Announces Second Quarter Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Achieves second quarter revenue growth of 11%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $3.63,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.72,revenues,up,"IDEXX Laboratories Inc.: Increases 2025 revenue guidance to $4,205 million - $4,280 million",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Updates guidance for 2025,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.64,earnings,up,IDEXX Laboratories Inc.: Updates 2025 EPS,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Second quarter earnings per diluted share,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,-0.68,revenues,down,IDEXX Laboratories Inc.: Rapid assay products revenues declined,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.68,revenues,up,IDEXX Laboratories Inc.: CAG Diagnostics capital instrument revenues expanded 66%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 12%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 33.6% for the quarter,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company updated its full year reported operating margin outlook,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact 0.7%,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -2-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -2-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.65,revenues,up,IDEXX Laboratories Inc.: Organic revenue growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share (diluted) $3.63 $ 2.44,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -3-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.64,earnings,up,IDEXX Laboratories Inc.: Comparable EPS growth $3.50 $ 3.00,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2025 comparable EPS growth,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: We report segment income from operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Annual Report on Form 10-K for the year ended December 31, 2024",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -4-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $1,109,457 $1,003,578",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -5-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 694,732",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -5-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -5-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $3.66 $2.46,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -5-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $3.63 $2.44,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -5-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.65,revenues,up,"Idexx Laboratories, Inc. and Subsidiaries Revenues and Revenue Growth",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -5-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,94,0.65,revenues,up,"Idexx Laboratories, Inc. and Subsidiaries Revenues and Revenue Growth",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -6-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,94,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $3,330,794 $3,293,443",PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -6-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -7-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.59,equity-actions,,IDEXX Laboratories Inc.: Repurchases of common stock,PRESS-RELEASE,Business Wire,IDEXX Laboratories Announces Second Quarter -7-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Second Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.41,revenues,up,IDEXX Laboratories Inc.: Achieves second quarter revenue growth of 11%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.61,earnings,positive,IDEXX Laboratories Inc.: Delivers EPS of $3.63,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.72,revenues,up,"IDEXX Laboratories Inc.: Increases 2025 revenue guidance to $4,205 million - $4,280 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Updates guidance for 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.64,earnings,up,IDEXX Laboratories Inc.: Updates 2025 EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,IDEXX Laboratories Inc.: Second quarter earnings per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,-0.68,revenues,down,IDEXX Laboratories Inc.: Rapid assay products revenues declined,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.68,revenues,up,IDEXX Laboratories Inc.: CAG Diagnostics capital instrument revenues expanded 66%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.4,earnings,up,IDEXX Laboratories Inc.: Gross profits increased 12%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: Operating margin was 33.6% for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,-0.49,equity-actions,up,IDEXX Laboratories Inc.: Comparable operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,revenues,,IDEXX Laboratories Inc.: The Company updated its full year reported operating margin outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces Second Quarter Results
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.41,revenues,up,IDEXX Laboratories Inc.: Revenue growth rate impact 0.7%,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -2-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,investor-relations,,"Idexx Laboratories, Inc. will be hosting a conference call today at 8:30 a.m. (EDT)",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -2-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.64,earnings,up,IDEXX Laboratories Inc.: Comparable EPS growth $3.50 $ 3.00,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,IDEXX Laboratories Inc.: Projected 2025 comparable EPS growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: We report segment income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.46,equity-actions,,IDEXX Laboratories Inc.: the Company's investments in property and equipment,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: To calculate trailing twelve-month net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,IDEXX Laboratories Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Annual Report on Form 10-K for the year ended December 31, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,99,0.0,earnings,,"IDEXX Laboratories Inc.: the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -4-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.0,revenues,,"IDEXX Laboratories Inc.: Revenue: Revenue $1,109,457 $1,003,578",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -5-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.61,earnings,positive,"IDEXX Laboratories Inc.: Gross profit 694,732",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -5-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.0,earnings,,IDEXX Laboratories Inc.: Income from operations,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -5-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Basic $3.66 $2.46,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -5-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.61,earnings,positive,IDEXX Laboratories Inc.: Earnings per share: Diluted $3.63 $2.44,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -5-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.65,revenues,up,"Idexx Laboratories, Inc. and Subsidiaries Revenues and Revenue Growth",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -5-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,94,0.65,revenues,up,"Idexx Laboratories, Inc. and Subsidiaries Revenues and Revenue Growth",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -6-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,94,0.0,assets,,"IDEXX Laboratories Inc.: Total assets $3,330,794 $3,293,443",PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -6-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.0,revenues,,IDEXX Laboratories Inc.: 1) Days sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -7-
IDXX,2025-08-04,10:30:02,B7EB38,IDEXX Laboratories Inc.,95,0.59,equity-actions,,IDEXX Laboratories Inc.: Repurchases of common stock,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Announces -7-
IDXX,2025-08-04,10:31:04,B7EB38,IDEXX Laboratories Inc.,100,0.72,revenues,up,Idexx Labs Raises 2025 View To Rev $4.205B-$4.28B,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Raises 2025 View To Rev $4.205B-$4.28B >IDXX
IDXX,2025-08-04,10:31:20,B7EB38,IDEXX Laboratories Inc.,94,0.0,earnings,,"IDEXX Laboratories Inc.: the ""Company"") announced its financial results for the quarter ended June 30, 2025",RNS-SEC8K,Dow Jones Newswires,IDEXX Labs Files 8K - Operations And Financial Condition >IDXX
IDXX,2025-08-04,10:32:27,B7EB38,IDEXX Laboratories Inc.,100,0.7,earnings,up,Idexx Labs Raises 2025 View To EPS $12.40,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Raises 2025 View To EPS $12.40-EPS $12.76 >IDXX
IDXX,2025-08-04,10:32:41,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Labs Had Seen 2025 EPS $11.93-$12.43 >IDXX,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Had Seen 2025 EPS $11.93-$12.43 >IDXX
IDXX,2025-08-04,13:27:35,B7EB38,IDEXX Laboratories Inc.,99,-0.42,assets,,Idexx sells lab equipment for,FULL-ARTICLE,Dow Jones Newswires,How Idexx Laboratories Is Riding The 'Puppy Boom' To New Highs -- IBD
IDXX,2025-08-04,13:27:35,B7EB38,IDEXX Laboratories Inc.,99,0.0,revenues,,Idexx notched $1.11 billion in sales,FULL-ARTICLE,Dow Jones Newswires,How Idexx Laboratories Is Riding The 'Puppy Boom' To New Highs -- IBD
IDXX,2025-08-04,13:27:35,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,Idexx Laboratories also hiked its outlook for the year,FULL-ARTICLE,Dow Jones Newswires,How Idexx Laboratories Is Riding The 'Puppy Boom' To New Highs -- IBD
IDXX,2025-08-04,13:53:02,B7EB38,IDEXX Laboratories Inc.,100,0.7,earnings,above-expectations,IDEXX Laboratories Inc.: the company reported second-quarter earnings that beat analysts' expectations,FULL-ARTICLE,Dow Jones Newswires,"Idexx Laboratories Shares Rise After 2Q Earnings, Revenue Beat Expectations"
IDXX,2025-08-04,13:53:02,B7EB38,IDEXX Laboratories Inc.,100,0.72,revenues,up,Idexx raised its 2025 revenue forecast to $4.205 billion to $4.28 billion,FULL-ARTICLE,Dow Jones Newswires,"Idexx Laboratories Shares Rise After 2Q Earnings, Revenue Beat Expectations"
IDXX,2025-08-04,20:08:07,B7EB38,IDEXX Laboratories Inc.,99,-0.42,assets,,Idexx sells lab equipment for,FULL-ARTICLE,Dow Jones Newswires,How Idexx Laboratories Is Riding The 'Puppy Boom' To New Highs -- IBD
IDXX,2025-08-04,20:08:07,B7EB38,IDEXX Laboratories Inc.,99,0.0,revenues,,Idexx notched $1.11 billion in sales,FULL-ARTICLE,Dow Jones Newswires,How Idexx Laboratories Is Riding The 'Puppy Boom' To New Highs -- IBD
IDXX,2025-08-04,20:08:07,B7EB38,IDEXX Laboratories Inc.,99,0.7,earnings,up,Idexx Laboratories also hiked its outlook for the year,FULL-ARTICLE,Dow Jones Newswires,How Idexx Laboratories Is Riding The 'Puppy Boom' To New Highs -- IBD
IDXX,2025-08-04,21:49:50,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by JP Morgan
IDXX,2025-08-04,21:49:50,B7EB38,IDEXX Laboratories Inc.,100,0.78,price-targets,upgrade,Idexx Labs Price Target Raised to $675.00/Share From $550.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $675.00/Share From $550.00 by JP Morgan
IDXX,2025-08-06,20:21:46,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Lane Registers 8,411 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Lane Registers 8,411 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-08-06,20:25:05,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Ceo Mazelsky Registers 29,260 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"CEO Mazelsky Registers 29,260 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-08-06,20:36:38,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Hunt Registers 7,143 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Hunt Registers 7,143 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-08-08,20:27:26,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Underberg Registers 5,450 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Underberg Registers 5,450 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-08-09,00:38:12,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Lane Sells 8,411 Of IDEXX Laboratories Inc",FULL-ARTICLE,Dow Jones Newswires,"VP Lane Sells 8,411 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-08-09,00:39:24,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Ceo Mazelsky Sells 29,260 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mazelsky Sells 29,260 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-08-09,01:01:24,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Hunt Sells 7,143 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Hunt Sells 7,143 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-08-11,12:31:45,B7EB38,IDEXX Laboratories Inc.,100,0.0,analyst-ratings,neutral,Idexx Labs Is Maintained at Neutral by Piper Sandler,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Neutral by Piper Sandler
IDXX,2025-08-11,12:31:45,B7EB38,IDEXX Laboratories Inc.,100,0.82,price-targets,upgrade,Idexx Labs Price Target Raised to $700.00/Share From $510.00 by Piper Sandler,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $700.00/Share From $510.00 by Piper Sandler
IDXX,2025-08-11,20:06:40,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Vp Hunt Registers 1,200 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"VP Hunt Registers 1,200 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-08-11,22:02:30,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,"Cfo Emerson Acquires 1,447 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Emerson Acquires 1,447 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-08-12,21:01:17,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Ceo Mazelsky Acquires 183 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,CEO Mazelsky Acquires 183 Of IDEXX Laboratories Inc >IDXX
IDXX,2025-08-12,21:02:01,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Underberg Sells 5,450 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Underberg Sells 5,450 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-08-12,22:33:30,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,Vp Erickson Registers 407 Of IDEXX Laboratories Inc >IDXX,RNS-SEC144,Dow Jones Newswires,VP Erickson Registers 407 Of IDEXX Laboratories Inc >IDXX
IDXX,2025-08-13,21:18:57,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Vp Hunt Sells 1,200 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Hunt Sells 1,200 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-08-14,22:02:58,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,Vp Erickson Sells 406 Of IDEXX Laboratories Inc,TABULAR-MATERIAL,Dow Jones Newswires,VP Erickson Sells 406 Of IDEXX Laboratories Inc >IDXX
IDXX,2025-08-15,12:54:34,B7EB38,IDEXX Laboratories Inc.,100,0.34,analyst-ratings,neutral,Idexx Labs Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Is Maintained at Overweight by Morgan Stanley
IDXX,2025-08-15,12:54:34,B7EB38,IDEXX Laboratories Inc.,100,0.62,price-targets,upgrade,Idexx Labs Price Target Raised to $765.00/Share From $722.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $765.00/Share From $722.00 by Morgan Stanley
IDXX,2025-08-19,07:01:02,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,"Idexx Laboratories Inc, Inst Holders, 2Q 2025 (IDXX)",RNS-SEC13F,Dow Jones Newswires,"IDEXX Laboratories  Inc, Inst Holders, 2Q 2025 (IDXX)"
IDXX,2025-08-22,20:12:30,B7EB38,IDEXX Laboratories Inc.,100,-0.48,insider-trading,,"Dir Szostak Registers 2,187 Of IDEXX Laboratories Inc >IDXX",RNS-SEC144,Dow Jones Newswires,"Dir Szostak Registers 2,187 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-08-26,21:01:28,B7EB38,IDEXX Laboratories Inc.,100,-0.49,insider-trading,,"Dir Szostak Sells 2,187 Of IDEXX Laboratories Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Szostak Sells 2,187 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-09-02,17:00:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
IDXX,2025-09-02,17:00:01,B7EB38,IDEXX Laboratories Inc.,100,0.0,marketing,,Idexx Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
IDXX,2025-09-03,21:57:30,B7EB38,IDEXX Laboratories Inc.,100,0.52,insider-trading,,Vp Smith Acquires 13 Of IDEXX Laboratories Inc >IDXX,TABULAR-MATERIAL,Dow Jones Newswires,VP Smith Acquires 13 Of IDEXX Laboratories Inc >IDXX
IDXX,2025-09-04,22:20:59,B7EB38,IDEXX Laboratories Inc.,100,0.0,insider-trading,,"Ceo Mazelsky Gifts 1,051 Of IDEXX Laboratories Inc >IDXX",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mazelsky Gifts 1,051 Of IDEXX Laboratories Inc >IDXX"
IDXX,2025-10-01,12:32:12,B7EB38,IDEXX Laboratories Inc.,100,0.01,analyst-ratings,neutral,Idexx Labs Initiated at Neutral by UBS,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Initiated at Neutral by UBS
IDXX,2025-10-01,12:32:12,B7EB38,IDEXX Laboratories Inc.,100,0.0,price-targets,set,Idexx Labs Price Target Announced at $720.00/Share by UBS,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Announced at $720.00/Share by UBS
IDXX,2025-10-07,11:00:00,B7EB38,IDEXX Laboratories Inc.,100,0.47,labor-issues,,Idexx Laboratories Elects Karen Peacock to Board of Directors,PRESS-RELEASE,Business Wire,IDEXX Laboratories Elects Karen Peacock to Board of Directors
IDXX,2025-10-07,11:00:03,B7EB38,IDEXX Laboratories Inc.,100,0.47,labor-issues,,Idexx Laboratories Elects Karen Peacock to Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: IDEXX Laboratories Elects Karen Peacock to Board of Directors
IDXX,2025-10-07,11:00:45,B7EB38,IDEXX Laboratories Inc.,100,0.47,labor-issues,,Idexx Laboratories Elects Karen Peacock to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,IDEXX Laboratories Elects Karen Peacock to Bd of Directors
IDXX,2025-10-08,18:00:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,earnings,,Idexx Laboratories to Release 2025 Third Quarter Financial Results,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2025 Third Quarter Financial Results
IDXX,2025-10-08,18:00:00,B7EB38,IDEXX Laboratories Inc.,100,0.0,investor-relations,,IDEXX Laboratories Inc.: Individuals can access a live webcast of the conference call,PRESS-RELEASE,Business Wire,IDEXX Laboratories to Release 2025 Third Quarter Financial Results
IDXX,2025-10-31,10:22:32,B7EB38,IDEXX Laboratories Inc.,100,0.94,analyst-ratings,positive,Idexx Labs Raised to Buy From Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Raised to Buy From Hold by Stifel
IDXX,2025-10-31,10:22:32,B7EB38,IDEXX Laboratories Inc.,100,0.76,price-targets,upgrade,Idexx Labs Price Target Raised to $700.00/Share From $640.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,IDEXX Labs Price Target Raised to $700.00/Share From $640.00 by Stifel
